[S02DA03, antipyrine, The metabolism of Clonidine can be decreased when combined with Antipyrine.]
[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Clonidine.]
[L04AA27, fingolimod, Clonidine may increase the bradycardic activities of Fingolimod.]
[M03AB01, succinylcholine, The risk or severity of sedation can be increased when Clonidine is combined with Succinylcholine.]
[J01EC01, sulfamethoxazole, The metabolism of Clonidine can be decreased when combined with Sulfamethoxazole.]
[M04AB02, sulfinpyrazone, The metabolism of Clonidine can be increased when combined with Sulfinpyrazone.]
[M01AB02, sulindac, The therapeutic efficacy of Clonidine can be decreased when used in combination with Sulindac.]
[N05AL01, sulpiride, The risk or severity of sedation can be increased when Clonidine is combined with Sulpiride.]
[N03AX03, sulthiame, The risk or severity of sedation can be increased when Clonidine is combined with Sulthiame.]
[M01AX04, apazone, The therapeutic efficacy of Clonidine can be decreased when used in combination with Azapropazone.]
[N06DA01, tacrine, The metabolism of Clonidine can be decreased when combined with Tacrine.]
[L02BA01, tamoxifen, The metabolism of Clonidine can be increased when combined with Tamoxifen.]
[N05CD07, temazepam, The risk or severity of sedation can be increased when Clonidine is combined with Temazepam.]
[L01CB02, teniposide, The metabolism of Clonidine can be decreased when combined with Teniposide.]
[R03CC03, terbutaline, Terbutaline may decrease the antihypertensive activities of Clonidine.]
[G03BA03, testosterone, The metabolism of Clonidine can be increased when combined with Testosterone.]
[N07XX06, tetrabenazine, The metabolism of Clonidine can be decreased when combined with Tetrabenazine.]
[S01HA03, tetracaine, The risk or severity of sedation can be increased when Clonidine is combined with Tetracaine.]
[S03AA02, tetracycline, The metabolism of Clonidine can be decreased when combined with Tetracycline.]
[N05AE05, lurasidone, The risk or severity of sedation can be increased when Clonidine is combined with Lurasidone.]
[A04AD10, dronabinol, The risk or severity of sedation can be increased when Clonidine is combined with Dronabinol.]
[N04BC07, apomorphine, The risk or severity of sedation can be increased when Clonidine is combined with Apomorphine.]
[L04AX02, thalidomide, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA07, theobromine, The metabolism of Theobromine can be decreased when combined with Clonidine.]
[R03DA04, theophylline, The metabolism of Clonidine can be decreased when combined with Theophylline.]
[P02CA02, thiabendazole, The metabolism of Clonidine can be decreased when combined with Thiabendazole.]
[R06AD03, thiethylperazine, The risk or severity of sedation can be increased when Clonidine is combined with Thiethylperazine.]
[N05CA19, thiopental, The risk or severity of sedation can be increased when Clonidine is combined with Thiopental.]
[N05AB08, thioproperazine, The risk or severity of sedation can be increased when Clonidine is combined with Thioproperazine.]
[N05AC02, thioridazine, The risk or severity of sedation can be increased when Clonidine is combined with Thioridazine.]
[N05AF04, thiothixene, The risk or severity of sedation can be increased when Clonidine is combined with Thiothixene.]
[C01BB04, aprindine, The metabolism of Clonidine can be decreased when combined with Aprindine.]
[G04BE06, moxisylyte, Moxisylyte may decrease the antihypertensive activities of Clonidine.]
[N05AL03, tiapride, The risk or severity of sedation can be increased when Clonidine is combined with Tiapride.]
[B01AC05, ticlopidine, The metabolism of Clonidine can be decreased when combined with Ticlopidine.]
[N02AX01, tilidine, The risk or severity of sedation can be increased when Clonidine is combined with Tilidine.]
[S01ED01, timolol, Timolol may increase the hypertensive activities of Clonidine.]
[M02AX02, tolazoline, The risk or severity of hypotension can be increased when Clonidine is combined with Tolazoline.]
[M02AA21, tolmetin, The therapeutic efficacy of Clonidine can be decreased when used in combination with Tolmetin.]
[M03BX04, tolperisone, The risk or severity of sedation can be increased when Clonidine is combined with Tolperisone.]
[N02AX02, tramadol, The risk or severity of sedation can be increased when Clonidine is combined with Tramadol.]
[N06AF04, tranylcypromine, The risk or severity of sedation can be increased when Clonidine is combined with Tranylcypromine.]
[N06AX05, trazodone, The risk or severity of sedation can be increased when Clonidine is combined with Trazodone.]
[L01XF01, tretinoin, The metabolism of Clonidine can be decreased when combined with Tretinoin.]
[S01BA05, triamcinolone, The metabolism of Clonidine can be increased when combined with Triamcinolone.]
[C03DB02, triamterene, The metabolism of Clonidine can be decreased when combined with Triamterene.]
[N05CD05, triazolam, The risk or severity of sedation can be increased when Clonidine is combined with Triazolam.]
[C03AA06, trichlormethiazide, The risk or severity of hypotension can be increased when Clonidine is combined with Trichlormethiazide.]
[A03AB12, mepenzolate, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[N05AB06, trifluoperazine, The risk or severity of sedation can be increased when Clonidine is combined with Trifluoperazine.]
[N05AD02, trifluperidol, The risk or severity of sedation can be increased when Clonidine is combined with Trifluperidol.]
[N05AA05, triflupromazine, The risk or severity of sedation can be increased when Clonidine is combined with Triflupromazine.]
[N04AA01, trihexyphenidyl, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[R03BA07, mometasone, The metabolism of Clonidine can be increased when combined with Mometasone.]
[A03AA05, trimebutine, Clonidine may increase the atrioventricular blocking (AV block) activities of Trimebutine.]
[S01ED04, metipranolol, Clonidine may increase the hypotensive activities of Metipranolol.]
[R06AD01, trimeprazine, The risk or severity of sedation can be increased when Clonidine is combined with Alimemazine.]
[N03AC02, trimethadione, The risk or severity of sedation can be increased when Clonidine is combined with Trimethadione.]
[C02BA01, trimethaphan, The risk or severity of hypotension can be increased when Clonidine is combined with Trimethaphan.]
[N06AA06, trimipramine, The risk or severity of sedation can be increased when Clonidine is combined with Trimipramine.]
[R06AC04, tripelennamine, The metabolism of Clonidine can be decreased when combined with Tripelennamine.]
[R06AX07, triprolidine, The risk or severity of sedation can be increased when Clonidine is combined with Triprolidine.]
[A03BB01, butylscopolamine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[J01FA08, troleandomycin, The metabolism of Clonidine can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The risk or severity of sedation can be increased when Clonidine is combined with Vilazodone.]
[N06AX02, tryptophan, The risk or severity of sedation can be increased when Clonidine is combined with Tryptophan.]
[C09CA09, azilsartan medoxomil, The risk or severity of hypotension can be increased when Clonidine is combined with Azilsartan medoxomil.]
[M03AA02, tubocurarine, The risk or severity of sedation can be increased when Clonidine is combined with Tubocurarine.]
[R03DX07, roflumilast, The metabolism of Clonidine can be decreased when combined with Roflumilast.]
[L02BX03, abiraterone, The serum concentration of Clonidine can be increased when it is combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Clonidine can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Clonidine can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Clonidine can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Clonidine can be decreased when combined with Rilpivirine.]
[N03AX21, ezogabine, The risk or severity of sedation can be increased when Clonidine is combined with Ezogabine.]
[B01AF01, rivaroxaban, The metabolism of Clonidine can be decreased when combined with Rivaroxaban.]
[R03AC18, indacaterol, Indacaterol may decrease the antihypertensive activities of Clonidine.]
[B01AC24, ticagrelor, The metabolism of Clonidine can be decreased when combined with Ticagrelor.]
[C08DA01, verapamil, Verapamil may increase the atrioventricular blocking (AV block) activities of Clonidine.]
[N06AX09, viloxazine, The risk or severity of sedation can be increased when Clonidine is combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Clonidine can be increased when combined with Vinblastine.]
[C04AX07, vincamine, The risk or severity of hypotension can be increased when Clonidine is combined with Vincamine.]
[L01CA02, vincristine, The metabolism of Clonidine can be decreased when combined with Vincristine.]
[A11HA03, vitamin E, The metabolism of Clonidine can be increased when combined with Vitamin E.]
[B01AA03, warfarin, The metabolism of Clonidine can be increased when combined with Warfarin.]
[N01AX15, xenon, The therapeutic efficacy of Xenon can be increased when used in combination with Clonidine.]
[C03BA10, xipamide, The risk or severity of hypotension can be increased when Clonidine is combined with Xipamide.]
[N05AF05, zuclopenthixol, The risk or severity of sedation can be increased when Clonidine is combined with Zuclopenthixol.]
[J05AE02, indinavir, The metabolism of Clonidine can be decreased when combined with Indinavir.]
[N03AX14, levetiracetam, The risk or severity of sedation can be increased when Clonidine is combined with Levetiracetam.]
[L01EC01, vemurafenib, The serum concentration of Clonidine can be increased when it is combined with Vemurafenib.]
[L01FX05, brentuximab vedotin, The metabolism of Clonidine can be decreased when combined with Brentuximab vedotin.]
[L01ED01, crizotinib, The metabolism of Clonidine can be decreased when combined with Crizotinib.]
[R03DC01, zafirlukast, The metabolism of Clonidine can be decreased when combined with Zafirlukast.]
[J01MA13, trovafloxacin, The metabolism of Clonidine can be decreased when combined with Trovafloxacin.]
[N05AE04, ziprasidone, The risk or severity of sedation can be increased when Clonidine is combined with Ziprasidone.]
[G03AC10, drospirenone, The risk or severity of sedation can be increased when Drospirenone is combined with Clonidine.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the antihypertensive activities of Clonidine.]
[L01EJ01, ruxolitinib, Ruxolitinib may increase the bradycardic activities of Clonidine.]
[G04BD07, tolterodine, The metabolism of Clonidine can be decreased when combined with Tolterodine.]
[C07AB03, atenolol, The risk or severity of hypotension can be increased when Clonidine is combined with Atenolol.]
[L03AB11, peginterferon alfa-2a, The metabolism of Clonidine can be decreased when combined with Peginterferon alfa-2a.]
[L01FA01, rituximab, Clonidine may increase the hypotensive activities of Rituximab.]
[J02AC03, voriconazole, The metabolism of Clonidine can be decreased when combined with Voriconazole.]
[M03AC04, atracurium, The risk or severity of sedation can be increased when Clonidine is combined with Atracurium.]
[S01FA01, atropine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Atropine.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Clonidine.]
[R07AX02, ivacaftor, The metabolism of Clonidine can be decreased when combined with Ivacaftor.]
[H02AB11, prednylidene, The metabolism of Clonidine can be increased when combined with Prednylidene.]
[L04AX01, azathioprine, The metabolism of Azathioprine can be decreased when combined with Clonidine.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Clonidine.]
[M03BX01, baclofen, The risk or severity of sedation can be increased when Clonidine is combined with Baclofen.]
[A08AA11, lorcaserin, The risk or severity of sedation can be increased when Clonidine is combined with Lorcaserin.]
[G04BD12, mirabegron, The serum concentration of Clonidine can be increased when it is combined with Mirabegron.]
[V03AX03, cobicistat, The metabolism of Clonidine can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Clonidine can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Clonidine can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The metabolism of Clonidine can be decreased when combined with Bosutinib.]
[L04AA31, teriflunomide, The serum concentration of Clonidine can be decreased when it is combined with Teriflunomide.]
[C01CA18, octopamine, Octopamine may decrease the antihypertensive activities of Clonidine.]
[L01EX05, regorafenib, Clonidine may increase the bradycardic activities of Regorafenib.]
[N05CA04, barbital, The risk or severity of sedation can be increased when Clonidine is combined with Barbital.]
[C01AA01, acetyldigitoxin, Clonidine may increase the atrioventricular blocking (AV block) activities of Acetyldigitoxin.]
[J05AE04, nelfinavir, The metabolism of Clonidine can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The metabolism of Bendamustine can be decreased when combined with Clonidine.]
[S01GA07, brimonidine, Brimonidine may increase the antihypertensive activities of Clonidine.]
[N04BD02, rasagiline, The risk or severity of sedation can be increased when Clonidine is combined with Rasagiline.]
[C08CA13, lercanidipine, Clonidine may increase the atrioventricular blocking (AV block) activities of Lercanidipine.]
[A03FA09, mosapride, The risk or severity of sedation can be increased when Clonidine is combined with Mosapride.]
[N06DA02, donepezil, The risk or severity of sedation can be increased when Clonidine is combined with Donepezil.]
[N03AX22, perampanel, The risk or severity of sedation can be increased when Clonidine is combined with Perampanel.]
[L04AA29, tofacitinib, Clonidine may increase the bradycardic activities of Tofacitinib.]
[N02CC03, zolmitriptan, The risk or severity of sedation can be increased when Clonidine is combined with Zolmitriptan.]
[R06AC06, thonzylamine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, The metabolism of Clonidine can be decreased when combined with Darifenacin.]
[N01AB02, chloroform, The therapeutic efficacy of Chloroform can be increased when used in combination with Clonidine.]
[N01AA01, ethyl ether, The risk or severity of sedation can be increased when Clonidine is combined with Diethyl ether.]
[H01CB05, pasireotide, The metabolism of Clonidine can be decreased when combined with Pasireotide.]
[G04BE03, sildenafil, The metabolism of Clonidine can be decreased when combined with Sildenafil.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Clonidine.]
[B01AF02, apixaban, The metabolism of Clonidine can be decreased when combined with Apixaban.]
[C10AX12, lomitapide, The metabolism of Clonidine can be decreased when combined with Lomitapide.]
[C04AX11, bencyclane, Clonidine may increase the atrioventricular blocking (AV block) activities of Bencyclane.]
[A10BH04, alogliptin, The metabolism of Clonidine can be decreased when combined with Alogliptin.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Clonidine can be increased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, The risk or severity of hypotension can be increased when Clonidine is combined with Bendroflumethiazide.]
[L04AX06, pomalidomide, The risk or severity of sedation can be increased when Clonidine is combined with Pomalidomide.]
[G03XC05, ospemifene, The metabolism of Clonidine can be decreased when combined with Ospemifene.]
[N02BA10, benorilate, The therapeutic efficacy of Clonidine can be decreased when used in combination with Benorilate.]
[N05AD07, benperidol, The risk or severity of sedation can be increased when Clonidine is combined with Benperidol.]
[A10BK02, canagliflozin, The risk or severity of adverse effects can be increased when Clonidine is combined with Canagliflozin.]
[J01MA15, gemifloxacin, The metabolism of Clonidine can be decreased when combined with Gemifloxacin.]
[S01AE07, moxifloxacin, The metabolism of Clonidine can be decreased when combined with Moxifloxacin.]
[A06AX06, tegaserod, The metabolism of Clonidine can be decreased when combined with Tegaserod.]
[A10AE05, insulin detemir, The therapeutic efficacy of Insulin detemir can be increased when used in combination with Clonidine.]
[R02AD01, benzocaine, The risk or severity of sedation can be increased when Clonidine is combined with Benzocaine.]
[M01AH01, celecoxib, The metabolism of Clonidine can be decreased when combined with Celecoxib.]
[N02CC02, naratriptan, The risk or severity of sedation can be increased when Clonidine is combined with Naratriptan.]
[L04AA18, everolimus, The metabolism of Clonidine can be decreased when combined with Everolimus.]
[N04AC01, benztropine, The metabolism of Clonidine can be decreased when combined with Benzatropine.]
[L01EC02, dabrafenib, The serum concentration of Clonidine can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, The therapeutic efficacy of Clonidine can be decreased when used in combination with Benzydamine.]
[P03AX06, benzyl alcohol, The risk or severity of sedation can be increased when Clonidine is combined with Benzyl alcohol.]
[N06AX28, levomilnacipran, The risk or severity of sedation can be increased when Clonidine is combined with Levomilnacipran.]
[C08EA02, bepridil, Clonidine may increase the atrioventricular blocking (AV block) activities of Bepridil.]
[C02KX05, riociguat, The risk or severity of hypotension can be increased when Clonidine is combined with Riociguat.]
[C02KX04, macitentan, The risk or severity of hypotension can be increased when Clonidine is combined with Macitentan.]
[L01EL01, ibrutinib, The metabolism of Clonidine can be decreased when combined with Ibrutinib.]
[N06AX26, vortioxetine, The risk or severity of sedation can be increased when Clonidine is combined with Vortioxetine.]
[N03AF04, eslicarbazepine, The risk or severity of sedation can be increased when Clonidine is combined with Eslicarbazepine.]
[J05AP05, simeprevir, The metabolism of Clonidine can be decreased when combined with Simeprevir.]
[N03AG04, vigabatrin, The risk or severity of sedation can be increased when Clonidine is combined with Vigabatrin.]
[A10BK01, dapagliflozin, The metabolism of Clonidine can be decreased when combined with Dapagliflozin.]
[C01CA27, droxidopa, Droxidopa may decrease the antihypertensive activities of Clonidine.]
[C07AB04, acebutolol, The risk or severity of hypotension can be increased when Clonidine is combined with Acebutolol.]
[N05CH03, tasimelteon, The risk or severity of sedation can be increased when Clonidine is combined with Tasimelteon.]
[A16AA07, metreleptin, The metabolism of Clonidine can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Clonidine can be increased when combined with Apremilast.]
[L02BG02, formestane, The metabolism of Clonidine can be increased when combined with Formestane.]
[S03BA03, betamethasone, The metabolism of Clonidine can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, The risk or severity of hypotension can be increased when Clonidine is combined with Betaxolol.]
[C02CC01, bethanidine, The risk or severity of hypotension can be increased when Clonidine is combined with Bethanidine.]
[L04AC11, siltuximab, The metabolism of Clonidine can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, Clonidine may increase the bradycardic activities of Ceritinib.]
[B01AC26, vorapaxar, The metabolism of Clonidine can be decreased when combined with Vorapaxar.]
[A03BA03, hyoscyamine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Clonidine.]
[L01XH04, belinostat, The metabolism of Clonidine can be increased when combined with Belinostat.]
[L01EM01, idelalisib, The metabolism of Clonidine can be decreased when combined with Idelalisib.]
[N01AX05, alfaxalone, The risk or severity of sedation can be increased when Clonidine is combined with Alfaxalone.]
[A10BK03, empagliflozin, The risk or severity of adverse effects can be increased when Clonidine is combined with Empagliflozin.]
[R03AC19, olodaterol, Olodaterol may decrease the antihypertensive activities of Clonidine.]
[S01EE02, unoprostone, Clonidine may increase the hypotensive activities of Unoprostone.]
[D11AA01, glycopyrronium, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[N05CM19, suvorexant, The risk or severity of sedation can be increased when Clonidine is combined with Suvorexant.]
[A16AX10, eliglustat, The metabolism of Clonidine can be decreased when combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Clonidine can be increased when combined with Oritavancin.]
[N05AA04, acepromazine, The risk or severity of sedation can be increased when Clonidine is combined with Acepromazine.]
[A06AH03, naloxegol, The risk or severity of hypotension can be increased when Naloxegol is combined with Clonidine.]
[N04AA02, biperiden, The metabolism of Clonidine can be decreased when combined with Biperiden.]
[L04AX05, pirfenidone, The metabolism of Clonidine can be decreased when combined with Pirfenidone.]
[L01EX09, nintedanib, The metabolism of Clonidine can be decreased when combined with Nintedanib.]
[J05AP09, dasabuvir, The metabolism of Clonidine can be decreased when combined with Dasabuvir.]
[L01XK01, olaparib, The metabolism of Clonidine can be decreased when combined with Olaparib.]
[N06AX11, mirtazapine, The risk or severity of sedation can be increased when Clonidine is combined with Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Clonidine can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Clonidine can be decreased when combined with Palbociclib.]
[L01XH03, panobinostat, The metabolism of Clonidine can be decreased when combined with Panobinostat.]
[J05AP07, daclatasvir, The metabolism of Clonidine can be decreased when combined with Daclatasvir.]
[N02BE01, acetaminophen, The metabolism of Clonidine can be increased when combined with Acetaminophen.]
[A03AA09, difemerine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[C01EB17, ivabradine, Clonidine may increase the bradycardic activities of Ivabradine.]
[J05AP06, asunaprevir, The metabolism of Clonidine can be decreased when combined with Asunaprevir.]
[A07DA06, eluxadoline, The risk or severity of hypotension can be increased when Eluxadoline is combined with Clonidine.]
[N05AX16, brexpiprazole, The risk or severity of sedation can be increased when Clonidine is combined with Brexpiprazole.]
[A04AD14, rolapitant, The metabolism of Clonidine can be decreased when combined with Rolapitant.]
[G02CX02, flibanserin, The risk or severity of sedation can be increased when Clonidine is combined with Flibanserin.]
[N05AX15, cariprazine, The risk or severity of sedation can be increased when Clonidine is combined with Cariprazine.]
[M02AA25, aceclofenac, The therapeutic efficacy of Clonidine can be decreased when used in combination with Aceclofenac.]
[M01AB11, acemetacin, The therapeutic efficacy of Clonidine can be decreased when used in combination with Acemetacin.]
[S01EC01, acetazolamide, The risk or severity of sedation can be increased when Clonidine is combined with Acetazolamide.]
[A10AE06, insulin degludec, The therapeutic efficacy of Insulin degludec can be increased when used in combination with Clonidine.]
[N05AB07, acetophenazine, The risk or severity of sedation can be increased when Clonidine is combined with Acetophenazine.]
[A02BC03, lansoprazole, The metabolism of Clonidine can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Clonidine.]
[J02AC05, isavuconazole, The metabolism of Clonidine can be increased when combined with Isavuconazole.]
[L01EB04, osimertinib, The serum concentration of Clonidine can be decreased when it is combined with Osimertinib.]
[J05AF13, tenofovir alafenamide, The metabolism of Clonidine can be decreased when combined with Tenofovir alafenamide.]
[L01EE02, cobimetinib, The metabolism of Clonidine can be decreased when combined with Cobimetinib.]
[B01AC27, selexipag, The risk or severity of hypotension can be increased when Clonidine is combined with Selexipag.]
[G04CA01, alfuzosin, Alfuzosin may increase the hypotensive activities of Clonidine.]
[M04AB05, lesinurad, The metabolism of Clonidine can be increased when combined with Lesinurad.]
[J05AP10, elbasvir, The metabolism of Clonidine can be decreased when combined with Elbasvir.]
[N05CA05, aprobarbital, The risk or severity of sedation can be increased when Clonidine is combined with Aprobarbital.]
[M01AE16, alminoprofen, The therapeutic efficacy of Clonidine can be decreased when used in combination with Alminoprofen.]
[N03AX23, brivaracetam, The risk or severity of sedation can be increased when Clonidine is combined with Brivaracetam.]
[L01XX52, venetoclax, The metabolism of Clonidine can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, The risk or severity of sedation can be increased when Clonidine is combined with Bromazepam.]
[N04BC01, bromocriptine, The risk or severity of sedation can be increased when Clonidine is combined with Bromocriptine.]
[A03AX08, alverine, The risk or severity of sedation can be increased when Clonidine is combined with Alverine.]
[R06AB01, brompheniramine, The risk or severity of sedation can be increased when Clonidine is combined with Dexbrompheniramine.]
[N06AA19, amineptin, The risk or severity of sedation can be increased when Clonidine is combined with Amineptine.]
[C08CA01, amlodipine, Clonidine may increase the atrioventricular blocking (AV block) activities of Amlodipine.]
[N05AX17, pimavanserin, The metabolism of Clonidine can be decreased when combined with Pimavanserin.]
[N01AH05, anileridine, The therapeutic efficacy of Anileridine can be increased when used in combination with Clonidine.]
[N06BX11, aniracetam, The risk or severity of sedation can be increased when Clonidine is combined with Aniracetam.]
[A05AA04, obeticholic acid, The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Clonidine.]
[C03CA02, bumetanide, The risk or severity of adverse effects can be increased when Clonidine is combined with Bumetanide.]
[N01BB01, bupivacaine, The risk or severity of sedation can be increased when Clonidine is combined with Bupivacaine.]
[C07AA19, bupranolol, The risk or severity of hypotension can be increased when Clonidine is combined with Bupranolol.]
[N07BC01, buprenorphine, The risk or severity of sedation can be increased when Clonidine is combined with Buprenorphine.]
[N05BE01, buspirone, The risk or severity of sedation can be increased when Clonidine is combined with Buspirone.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Clonidine is combined with Arsenic trioxide.]
[N06DA03, rivastigmine, Clonidine may increase the bradycardic activities of Rivastigmine.]
[P01BE02, artemether, The metabolism of Clonidine can be decreased when combined with Artemether.]
[N02AF01, butorphanol, The risk or severity of sedation can be increased when Clonidine is combined with Butorphanol.]
[S01GX07, azelastine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[L01XK03, rucaparib, The metabolism of Clonidine can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The metabolism of Clonidine can be decreased when combined with Azithromycin.]
[L01EF02, ribociclib, The metabolism of Clonidine can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, The therapeutic efficacy of Clonidine can be decreased when used in combination with Balsalazide.]
[R03CC12, bambuterol, Bambuterol may decrease the antihypertensive activities of Clonidine.]
[R03DA08, bamifylline, The metabolism of Bamifylline can be decreased when combined with Clonidine.]
[N07XX16, deutetrabenazine, The metabolism of Clonidine can be decreased when combined with Deutetrabenazine.]
[N02BF02, pregabalin, The risk or severity of sedation can be increased when Clonidine is combined with Pregabalin.]
[N03AX30, beclamide, The risk or severity of sedation can be increased when Clonidine is combined with Beclamide.]
[N06BC01, caffeine, The metabolism of Clonidine can be decreased when combined with Caffeine.]
[C09AA07, benazepril, The risk or severity of hypotension can be increased when Clonidine is combined with Benazepril.]
[S01HA02, benoxinate, The risk or severity of sedation can be increased when Clonidine is combined with Oxybuprocaine.]
[D05AX03, calcitriol, The metabolism of Clonidine can be increased when combined with Calcitriol.]
[J01XX08, linezolid, Linezolid may increase the hypertensive activities of Clonidine.]
[J05AE09, tipranavir, The metabolism of Clonidine can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Clonidine can be decreased when combined with Valbenazine.]
[L04AB02, infliximab, The metabolism of Clonidine can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Clonidine can be decreased when combined with Midostaurin.]
[N04BD03, safinamide, The risk or severity of sedation can be increased when Clonidine is combined with Safinamide.]
[L04AC14, sarilumab, The metabolism of Clonidine can be increased when combined with Sarilumab.]
[D01AC10, bifonazole, The metabolism of Clonidine can be decreased when combined with Bifonazole.]
[L01XX59, enasidenib, The metabolism of Clonidine can be increased when combined with Enasidenib.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Clonidine.]
[C07AB07, bisoprolol, The risk or severity of adverse effects can be increased when Bisoprolol is combined with Clonidine.]
[R03AC17, bitolterol, Bitolterol may decrease the antihypertensive activities of Clonidine.]
[J05AG03, efavirenz, The risk or severity of sedation can be increased when Clonidine is combined with Efavirenz.]
[C07AA17, bopindolol, The risk or severity of adverse effects can be increased when Clonidine is combined with Bopindolol.]
[N04AA11, bornaprine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Clonidine is combined with Nesiritide.]
[N05AD06, bromperidol, The risk or severity of sedation can be increased when Clonidine is combined with Bromperidol.]
[N05CD09, brotizolam, The risk or severity of sedation can be increased when Clonidine is combined with Brotizolam.]
[R03BA02, budesonide, The metabolism of Clonidine can be increased when combined with Budesonide.]
[C04AX20, buflomedil, Buflomedil may decrease the antihypertensive activities of Clonidine.]
[M01AB07, bumadizone, The therapeutic efficacy of Clonidine can be decreased when used in combination with Bumadizone.]
[L01EL02, acalabrutinib, The metabolism of Clonidine can be decreased when combined with Acalabrutinib.]
[N05CA03, butobarbital, The risk or severity of sedation can be increased when Clonidine is combined with Butobarbital.]
[J05AX18, letermovir, The metabolism of Clonidine can be decreased when combined with Letermovir.]
[N06AA15, butriptyline, The risk or severity of sedation can be increased when Clonidine is combined with Butriptyline.]
[C01AA02, acetyldigoxins, Clonidine may increase the atrioventricular blocking (AV block) activities of Acetyldigoxin.]
[N01BX04, capsaicin, The metabolism of Clonidine can be decreased when combined with Capsaicin.]
[N05CA08, butylvinal, The risk or severity of sedation can be increased when Clonidine is combined with Vinylbital.]
[C09AA01, captopril, The risk or severity of hypotension can be increased when Clonidine is combined with Captopril.]
[V04CD06, macimorelin, The therapeutic efficacy of Macimorelin can be decreased when used in combination with Clonidine.]
[L02BB05, apalutamide, The metabolism of Clonidine can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The risk or severity of sedation can be increased when Clonidine is combined with Carbamazepine.]
[A03AA03, camylofine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[R06AA08, carbinoxamine, The risk or severity of sedation can be increased when Clonidine is combined with Carbinoxamine.]
[L03AB06, interferon alfa-n1, The metabolism of Clonidine can be decreased when combined with Interferon alfa-n1.]
[C07AG02, carvedilol, Clonidine may increase the atrioventricular blocking (AV block) activities of Carvedilol.]
[B02BX09, fostamatinib, The metabolism of Clonidine can be decreased when combined with Fostamatinib.]
[N03AX24, cannabidiol, The risk or severity of sedation can be increased when Clonidine is combined with Cannabidiol.]
[L01EC03, encorafenib, The metabolism of Clonidine can be decreased when combined with Encorafenib.]
[L01EE03, binimetinib, The metabolism of Binimetinib can be decreased when combined with Clonidine.]
[C07AB08, celiprolol, The risk or severity of hypotension can be increased when Clonidine is combined with Celiprolol.]
[H01CC03, elagolix, The metabolism of Clonidine can be decreased when combined with Elagolix.]
[L01XX62, ivosidenib, The metabolism of Clonidine can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Clonidine can be decreased when combined with Tafenoquine.]
[N03AX17, stiripentol, The risk or severity of sedation can be increased when Clonidine is combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Clonidine can be increased when combined with Tecovirimat.]
[J05AG06, doravirine, The metabolism of Clonidine can be decreased when combined with Doravirine.]
[L01EM04, duvelisib, The metabolism of Clonidine can be decreased when combined with Duvelisib.]
[L01EB07, dacomitinib, The metabolism of Clonidine can be decreased when combined with Dacomitinib.]
[S01GX12, cetirizine, The risk or severity of sedation can be increased when Clonidine is combined with Cetirizine.]
[N05CM04, carbromal, The risk or severity of sedation can be increased when Clonidine is combined with Carbromal.]
[N01BA04, chloroprocaine, The risk or severity of sedation can be increased when Clonidine is combined with Chloroprocaine.]
[R06AA06, chlorphenoxamine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[M01AC05, lornoxicam, The therapeutic efficacy of Clonidine can be decreased when used in combination with Lornoxicam.]
[R03DA02, oxtriphylline, The metabolism of Oxtriphylline can be decreased when combined with Clonidine.]
[M03BA02, carisoprodol, The risk or severity of sedation can be increased when Clonidine is combined with Carisoprodol.]
[R03BB08, revefenacin, The metabolism of Clonidine can be decreased when combined with Revefenacin.]
[L01ED05, lorlatinib, The metabolism of Clonidine can be increased when combined with Lorlatinib.]
[L04AA39, emapalumab, The metabolism of Clonidine can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The metabolism of Clonidine can be decreased when combined with Carmustine.]
[L01EX13, gilteritinib, The metabolism of Clonidine can be decreased when combined with Gilteritinib.]
[C09AA08, cilazapril, The risk or severity of hypotension can be increased when Clonidine is combined with Cilazapril.]
[B01AC23, cilostazol, The metabolism of Clonidine can be decreased when combined with Cilostazol.]
[A03FA08, cinitapride, The risk or severity of sedation can be increased when Clonidine is combined with Cinitapride.]
[S01ED05, carteolol, Carteolol may increase the hypotensive activities of Clonidine.]
[P02BX04, triclabendazole, The metabolism of Clonidine can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The risk or severity of sedation can be increased when Clonidine is combined with Esketamine.]
[L04AA42, siponimod, The metabolism of Clonidine can be decreased when combined with Siponimod.]
[J01FA09, clarithromycin, The metabolism of Clonidine can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, The risk or severity of sedation can be increased when Clonidine is combined with Solriamfetol.]
[N06AX29, brexanolone, The risk or severity of sedation can be increased when Clonidine is combined with Brexanolone.]
[N05BA09, clobazam, The risk or severity of sedation can be increased when Clonidine is combined with Clobazam.]
[H02AB14, cloprednol, The metabolism of Clonidine can be increased when combined with Cloprednol.]
[N05BA22, cloxazolam, The risk or severity of sedation can be increased when Clonidine is combined with Cloxazolam.]
[C09CA06, candesartan, The risk or severity of hypotension can be increased when Clonidine is combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Clonidine can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Clonidine can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The metabolism of Clonidine can be increased when combined with Alpelisib.]
[N05AA06, cyamemazine, The risk or severity of sedation can be increased when Clonidine is combined with Cyamemazine.]
[C03BX03, cicletanine, The risk or severity of hypotension can be increased when Clonidine is combined with Cicletanine.]
[M03BX08, cyclobenzaprine, The risk or severity of sedation can be increased when Clonidine is combined with Cyclobenzaprine.]
[L01EJ02, fedratinib, The metabolism of Clonidine can be decreased when combined with Fedratinib.]
[N07XX11, pitolisant, The serum concentration of Clonidine can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The metabolism of Clonidine can be decreased when combined with Pretomanid.]
[J01XX12, lefamulin, The serum concentration of Clonidine can be increased when it is combined with Lefamulin.]
[N04CX01, istradefylline, The metabolism of Clonidine can be decreased when combined with Istradefylline.]
[C03AA09, cyclothiazide, The risk or severity of hypotension can be increased when Clonidine is combined with Cyclothiazide.]
[G04BE04, yohimbine, The risk or severity of sedation can be increased when Clonidine is combined with Yohimbine.]
[A10AE03, insulin, regular, pork, The therapeutic efficacy of Insulin pork can be increased when used in combination with Clonidine.]
[J01DB01, cephalexin, The metabolism of Clonidine can be decreased when combined with Cephalexin.]
[J01DB09, cephradine, The metabolism of Clonidine can be increased when combined with Cefradine.]
[H02AB13, deflazacort, The metabolism of Clonidine can be increased when combined with Deflazacort.]
[G03DB05, demegestone, The risk or severity of sedation can be increased when Demegestone is combined with Clonidine.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Clonidine.]
[N02CC08, lasmiditan, The risk or severity of sedation can be increased when Clonidine is combined with Lasmiditan.]
[G03AC09, desogestrel, The risk or severity of sedation can be increased when Desogestrel is combined with Clonidine.]
[B06AX03, voxelotor, The serum concentration of Clonidine can be increased when it is combined with Voxelotor.]
[N03AX25, cenobamate, The serum concentration of Clonidine can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Clonidine can be increased when it is combined with Givosiran.]
[R06AB06, dexbrompheniramine, The risk or severity of sedation can be increased when Clonidine is combined with Dexbrompheniramine.]
[R06AB02, dexchlorpheniramine, The metabolism of Clonidine can be decreased when combined with Dexchlorpheniramine.]
[N02AX03, dezocine, The risk or severity of sedation can be increased when Clonidine is combined with Dezocine.]
[N05CM21, lemborexant, The risk or severity of sedation can be increased when Clonidine is combined with Lemborexant.]
[L01XX72, tazemetostat, The metabolism of Clonidine can be decreased when combined with Tazemetostat.]
[N05AD10, lumateperone, The risk or severity of sedation can be increased when Clonidine is combined with Lumateperone.]
[M01AX21, diacetylrhein, The metabolism of Clonidine can be decreased when combined with Diacerein.]
[J05AB16, remdesivir, The metabolism of Clonidine can be decreased when combined with Remdesivir.]
[S01AE06, gatifloxacin, The metabolism of Clonidine can be decreased when combined with Gatifloxacin.]
[H02CA02, osilodrostat, The serum concentration of Clonidine can be increased when it is combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Clonidine can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, The risk or severity of sedation can be increased when Clonidine is combined with Frovatriptan.]
[G04CB02, dutasteride, The metabolism of Clonidine can be decreased when combined with Dutasteride.]
[N05CC04, dichloralphenazone, The risk or severity of sedation can be increased when Clonidine is combined with Dichloralphenazone.]
[L01EE04, selumetinib, The metabolism of Clonidine can be decreased when combined with Selumetinib.]
[G03DB08, dienogest, The risk or severity of sedation can be increased when Dienogest is combined with Clonidine.]
[A07DA04, difenoxin, The risk or severity of sedation can be increased when Clonidine is combined with Difenoxin.]
[N02AA08, dihydrocodeine, The risk or severity of sedation can be increased when Clonidine is combined with Dihydrocodeine.]
[N02CC06, eletriptan, The risk or severity of sedation can be increased when Clonidine is combined with Eletriptan.]
[M01AH02, rofecoxib, The metabolism of Clonidine can be increased when combined with Rofecoxib.]
[L01XF03, bexarotene, The metabolism of Clonidine can be increased when combined with Bexarotene.]
[C08CA16, clevidipine, Clonidine may increase the atrioventricular blocking (AV block) activities of Clevidipine.]
[C01BD07, dronedarone, The serum concentration of Clonidine can be increased when it is combined with Dronedarone.]
[N03AG02, dipropylacetamide, The risk or severity of sedation can be increased when Clonidine is combined with Valpromide.]
[J01FA13, dirithromycin, The metabolism of Clonidine can be decreased when combined with Dirithromycin.]
[S03AA08, chloramphenicol, The metabolism of Clonidine can be decreased when combined with Chloramphenicol.]
[N05BA02, chlordiazepoxide, The risk or severity of sedation can be increased when Clonidine is combined with Chlordiazepoxide.]
[C02AA06, methoserpidine, The risk or severity of hypotension can be increased when Clonidine is combined with Methoserpidine.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Clonidine.]
[A03AA08, dihexyverine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[L01EX17, capmatinib, The serum concentration of Clonidine can be increased when it is combined with Capmatinib.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Clonidine is combined with Opicapone.]
[C01CA14, dopexamine, Dopexamine may decrease the antihypertensive activities of Clonidine.]
[D07XB03, fluprednidene, The metabolism of Clonidine can be increased when combined with Fluprednidene.]
[G04BD09, trospium, The metabolism of Clonidine can be decreased when combined with Trospium.]
[M01AC04, droxicam, The therapeutic efficacy of Clonidine can be decreased when used in combination with Droxicam.]
[L01EX22, selpercatinib, Selpercatinib may decrease the antihypertensive activities of Clonidine.]
[M02AA27, dexketoprofen, The therapeutic efficacy of Clonidine can be decreased when used in combination with Dexketoprofen.]
[N05CM02, chlormethiazole, The risk or severity of sedation can be increased when Clonidine is combined with Clomethiazole.]
[M03BB02, chlormezanone, The risk or severity of sedation can be increased when Clonidine is combined with Chlormezanone.]
[R02AD04, dyclonine, The risk or severity of sedation can be increased when Clonidine is combined with Dyclonine.]
[C08CA17, levamlodipine, Clonidine may increase the atrioventricular blocking (AV block) activities of Levamlodipine.]
[R06AX22, ebastine, The metabolism of Clonidine can be decreased when combined with Ebastine.]
[P01BB01, proguanil, The metabolism of Clonidine can be decreased when combined with Proguanil.]
[N05CD14, remimazolam, The risk or severity of sedation can be increased when Clonidine is combined with Remimazolam.]
[L04AC19, satralizumab, The serum concentration of Clonidine can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of sedation can be increased when Clonidine is combined with Oliceridine.]
[P01BA01, chloroquine, The metabolism of Clonidine can be decreased when combined with Chloroquine.]
[L01EX23, pralsetinib, The metabolism of Clonidine can be increased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, The risk or severity of hypotension can be increased when Clonidine is combined with Chlorothiazide.]
[R06AB04, chlorpheniramine, The risk or severity of sedation can be increased when Clonidine is combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The risk or severity of sedation can be increased when Clonidine is combined with Chlorpromazine.]
[N05AF03, chlorprothixene, The risk or severity of sedation can be increased when Clonidine is combined with Chlorprothixene.]
[M03BB03, chlorzoxazone, The risk or severity of sedation can be increased when Clonidine is combined with Chlorzoxazone.]
[A11CC05, cholecalciferol, The metabolism of Clonidine can be decreased when combined with Cholecalciferol.]
[N05BX03, etifoxine, The risk or severity of sedation can be increased when Clonidine is combined with Etifoxine.]
[N02BA07, ethenzamide, The therapeutic efficacy of Clonidine can be decreased when used in combination with Ethenzamide.]
[N06BX18, vinpocetine, The risk or severity of sedation can be increased when Clonidine is combined with Vinpocetine.]
[N05BA18, ethyl loflazepate, The risk or severity of sedation can be increased when Clonidine is combined with Ethyl loflazepate.]
[M01AB08, etodolac, The therapeutic efficacy of Clonidine can be decreased when used in combination with Etodolac.]
[M02AA06, etofenamate, The therapeutic efficacy of Clonidine can be decreased when used in combination with Etofenamate.]
[B06AC06, berotralstat, The serum concentration of Clonidine can be increased when it is combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Clonidine can be decreased when combined with Lonafarnib.]
[L02BX04, relugolix, The metabolism of Clonidine can be decreased when combined with Relugolix.]
[L01FX21, naxitamab, Naxitamab may decrease the antihypertensive activities of Clonidine.]
[P03AX07, abametapir, The serum concentration of Clonidine can be increased when it is combined with Abametapir.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Clonidine is combined with Vericiguat.]
[V03AF12, trilaciclib, The metabolism of Clonidine can be increased when combined with Trilaciclib.]
[M03BA05, febarbamate, The risk or severity of sedation can be increased when Clonidine is combined with Febarbamate.]
[N03AX10, felbamate, The risk or severity of sedation can be increased when Clonidine is combined with Felbamate.]
[M01AE05, fenbufen, The therapeutic efficacy of Clonidine can be decreased when used in combination with Fenbufen.]
[N06BA10, fenethylline, The metabolism of Fenethylline can be decreased when combined with Clonidine.]
[C01CA19, fenoldopam, The risk or severity of hypotension can be increased when Clonidine is combined with Fenoldopam.]
[N06BA08, fenozolone, Fenozolone may decrease the antihypertensive activities of Clonidine.]
[G04CB01, finasteride, The metabolism of Clonidine can be decreased when combined with Finasteride.]
[J01MB07, flumequine, The metabolism of Clonidine can be decreased when combined with Flumequine.]
[R03BA03, flunisolide, The metabolism of Clonidine can be increased when combined with Flunisolide.]
[R03CC15, formoterol, Clonidine may increase the sympathomimetic activities of Formoterol.]
[A10AF01, insulin, regular, human, The therapeutic efficacy of Insulin human can be increased when used in combination with Clonidine.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Clonidine.]
[N01AB05, trichloroethylene, The risk or severity of sedation can be increased when Clonidine is combined with Trichloroethylene.]
[L03AB10, peginterferon alfa-2b, The serum concentration of Clonidine can be increased when it is combined with Peginterferon alfa-2b.]
[H04AA02, dasiglucagon, The risk or severity of hypotension can be increased when Clonidine is combined with Dasiglucagon.]
[A02BA01, cimetidine, The metabolism of Clonidine can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, The risk or severity of sedation can be increased when Clonidine is combined with Gabapentin.]
[N07CA02, cinnarizine, Clonidine may increase the atrioventricular blocking (AV block) activities of Cinnarizine.]
[J01MB06, cinoxacin, The metabolism of Clonidine can be decreased when combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Clonidine can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Clonidine can be decreased when combined with Infigratinib.]
[S03AA07, ciprofloxacin, The metabolism of Clonidine can be decreased when combined with Ciprofloxacin.]
[N06AB04, citalopram, The risk or severity of sedation can be increased when Clonidine is combined with Citalopram.]
[H01AC07, somapacitan, The metabolism of Clonidine can be increased when combined with Somapacitan.]
[P01CA03, fexinidazole, The risk or severity of adverse effects can be increased when Clonidine is combined with Fexinidazole.]
[L01XX74, belzutifan, The serum concentration of Clonidine can be decreased when it is combined with Belzutifan.]
[H01AC09, lonapegsomatropin, The metabolism of Clonidine can be increased when combined with Lonapegsomatropin.]
[L01EB10, mobocertinib, The serum concentration of Clonidine can be decreased when it is combined with Mobocertinib.]
[L04AA59, avacopan, The metabolism of Clonidine can be decreased when combined with Avacopan.]
[R06AA04, clemastine, The risk or severity of sedation can be increased when Clonidine is combined with Clemastine.]
[R03CC13, clenbuterol, Clenbuterol may decrease the antihypertensive activities of Clonidine.]
[J01FF01, clindamycin, The metabolism of Clonidine can be decreased when combined with Clindamycin.]
[N06AX25, St. John's wort extract, The risk or severity of sedation can be increased when Clonidine is combined with St. John's Wort.]
[L01EA06, asciminib, The serum concentration of Clonidine can be increased when it is combined with Asciminib.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Clonidine.]
[J04BA01, clofazimine, The metabolism of Clonidine can be decreased when combined with Clofazimine.]
[C10AB01, clofibrate, The metabolism of Clonidine can be increased when combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Clonidine can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of sedation can be increased when Clonidine is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Clonidine can be increased when it is combined with Pacritinib.]
[N06AA04, clomipramine, The risk or severity of sedation can be increased when Clonidine is combined with Clomipramine.]
[N03AE01, clonazepam, The risk or severity of sedation can be increased when Clonidine is combined with Clonazepam.]
[S01AA13, fusidic acid, The metabolism of Clonidine can be decreased when combined with Fusidic acid.]
[J01MB04, pipemidic acid, The metabolism of Clonidine can be decreased when combined with Pipemidic acid.]
[N07XX04, sodium oxybate, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[S02BA08, fluocinolone acetonide, The metabolism of Clonidine can be increased when combined with Fluocinolone acetonide.]
[M01AG01, mefenamic acid, The therapeutic efficacy of Clonidine can be decreased when used in combination with Mefenamic acid.]
[C01EB24, mavacamten, The serum concentration of Clonidine can be decreased when it is combined with Mavacamten.]
[A02BC08, vonoprazan, The metabolism of Clonidine can be decreased when combined with Vonoprazan.]
[N05AH06, clothiapine, The risk or severity of sedation can be increased when Clonidine is combined with Clothiapine.]
[N05BA21, clotiazepam, The risk or severity of sedation can be increased when Clonidine is combined with Clotiazepam.]
[A04AA01, ondansetron, The risk or severity of sedation can be increased when Clonidine is combined with Ondansetron.]
[A04AA02, granisetron, The risk or severity of sedation can be increased when Clonidine is combined with Granisetron.]
[J05AX31, lenacapavir, The metabolism of Clonidine can be decreased when combined with Lenacapavir.]
[N05AH02, clozapine, The risk or severity of sedation can be increased when Clonidine is combined with Clozapine.]
[N05BA13, halazepam, The risk or severity of sedation can be increased when Clonidine is combined with Halazepam.]
[H01AC08, somatrogon, The metabolism of Clonidine can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The metabolism of Clonidine can be decreased when combined with Cocaine.]
[C02KB01, metyrosine, The risk or severity of hypotension can be increased when Clonidine is combined with Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Clonidine can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The therapeutic efficacy of Clonidine can be decreased when used in combination with Proquazone.]
[R05DA04, codeine, The risk or severity of sedation can be increased when Clonidine is combined with Codeine.]
[M03AC05, hexafluorenium, The risk or severity of sedation can be increased when Clonidine is combined with Hexafluronium.]
[A03AB10, hexocyclium, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[L04AA13, leflunomide, The serum concentration of Clonidine can be decreased when it is combined with Leflunomide.]
[N01AB07, desflurane, The risk or severity of sedation can be increased when Clonidine is combined with Desflurane.]
[A04AA03, tropisetron, The risk or severity of sedation can be increased when Clonidine is combined with Tropisetron.]
[C04AX28, ifenprodil, The risk or severity of sedation can be increased when Clonidine is combined with Ifenprodil.]
[A10BX03, nateglinide, The metabolism of Clonidine can be decreased when combined with Nateglinide.]
[N02BA16, imidazole-2-hydroxybenzoate, The therapeutic efficacy of Clonidine can be decreased when used in combination with Imidazole salicylate.]
[A10AE04, insulin glargine, The therapeutic efficacy of Insulin glargine can be increased when used in combination with Clonidine.]
[J01FA15, telithromycin, The metabolism of Clonidine can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The metabolism of Clonidine can be decreased when combined with Ciclesonide.]
[B01AC10, indobufen, The therapeutic efficacy of Clonidine can be decreased when used in combination with Indobufen.]
[R06AX27, desloratadine, The risk or severity of sedation can be increased when Clonidine is combined with Desloratadine.]
[M01AH03, valdecoxib, The therapeutic efficacy of Clonidine can be decreased when used in combination with Valdecoxib.]
[C01AA06, lanatoside C, Clonidine may increase the atrioventricular blocking (AV block) activities of Lanatoside C.]
[A03AX10, isometheptene, Isometheptene may decrease the antihypertensive activities of Clonidine.]
[N02CC05, almotriptan, The risk or severity of sedation can be increased when Clonidine is combined with Almotriptan.]
[M01AH04, parecoxib, The therapeutic efficacy of Clonidine can be decreased when used in combination with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Clonidine can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, The metabolism of Acyclovir can be decreased when combined with Clonidine.]
[N05BA10, ketazolam, The risk or severity of sedation can be increased when Clonidine is combined with Ketazolam.]
[M01AA06, kebuzone, The therapeutic efficacy of Clonidine can be decreased when used in combination with Kebuzone.]
[L01EA01, imatinib, The serum concentration of Clonidine can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Clonidine can be decreased when combined with Posaconazole.]
[S01EE04, travoprost, Travoprost may increase the hypotensive activities of Clonidine.]
[S01EE03, bimatoprost, Clonidine may increase the hypotensive activities of Bimatoprost.]
[C08CA09, lacidipine, Clonidine may increase the atrioventricular blocking (AV block) activities of Lacidipine.]
[N03AX09, lamotrigine, The risk or severity of sedation can be increased when Clonidine is combined with Lamotrigine.]
[S01GX02, levocabastine, The risk or severity of sedation can be increased when Clonidine is combined with Levocabastine.]
[S01BA03, cortisone, The metabolism of Clonidine can be increased when combined with Cortisone.]
[N07BC04, lofexidine, The risk or severity of sedation can be increased when Clonidine is combined with Lofexidine.]
[S01AE04, lomefloxacin, The metabolism of Lomefloxacin can be decreased when combined with Clonidine.]
[M01AB09, lonazolac, The therapeutic efficacy of Clonidine can be decreased when used in combination with Lonazolac.]
[N05CD06, lormetazepam, The risk or severity of sedation can be increased when Clonidine is combined with Lormetazepam.]
[M02AA31, loxoprofen, The therapeutic efficacy of Clonidine can be decreased when used in combination with Loxoprofen.]
[C09AA03, lisinopril, The risk or severity of hypotension can be increased when Clonidine is combined with Lisinopril.]
[C08CA11, manidipine, Clonidine may increase the atrioventricular blocking (AV block) activities of Manidipine.]
[A03AA04, mebeverine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, The risk or severity of sedation can be increased when Clonidine is combined with Medifoxamine.]
[A08AA09, mefenorex, Mefenorex may decrease the antihypertensive activities of Clonidine.]
[C07AA14, mepindolol, The risk or severity of adverse effects can be increased when Clonidine is combined with Mepindolol.]
[H02AB15, meprednisone, The metabolism of Clonidine can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The metabolism of Clonidine can be decreased when combined with Mequitazine.]
[C01EB10, adenosine, The risk or severity of Tachycardia can be increased when Clonidine is combined with Adenosine.]
[N04AA03, methixene, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[C04AX01, cyclandelate, Clonidine may increase the atrioventricular blocking (AV block) activities of Cyclandelate.]
[R03CB02, methoxyphenamine, Methoxyphenamine may decrease the antihypertensive activities of Clonidine.]
[R06AE03, cyclizine, The risk or severity of sedation can be increased when Clonidine is combined with Cyclizine.]
[N05CA10, cyclobarbital, The risk or severity of sedation can be increased when Clonidine is combined with Cyclobarbital.]
[C03DA04, eplerenone, The risk or severity of hypotension can be increased when Clonidine is combined with Eplerenone.]
[N05AD03, metylperon, The risk or severity of sedation can be increased when Clonidine is combined with Melperone.]
[C03AA07, cyclopenthiazide, The risk or severity of hypotension can be increased when Clonidine is combined with Cyclopenthiazide.]
[J01FA03, midecamycin, The metabolism of Clonidine can be decreased when combined with Midecamycin.]
[L01AA01, cyclophosphamide, The metabolism of Clonidine can be increased when combined with Cyclophosphamide.]
[N06AX07, minaprine, The risk or severity of sedation can be increased when Clonidine is combined with Minaprine.]
[S01XA18, cyclosporine, The metabolism of Clonidine can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, The risk or severity of sedation can be increased when Clonidine is combined with Moclobemide.]
[N06BA07, modafinil, The metabolism of Clonidine can be increased when combined with Modafinil.]
[R06AX02, cyproheptadine, The risk or severity of sedation can be increased when Clonidine is combined with Cyproheptadine.]
[C09AA13, moexipril, The risk or severity of hypotension can be increased when Clonidine is combined with Moexipril.]
[C10AA07, rosuvastatin, The metabolism of Clonidine can be decreased when combined with Rosuvastatin.]
[M02AA02, mofebutazone, The therapeutic efficacy of Clonidine can be decreased when used in combination with Mofebutazone.]
[M01AX22, morniflumate, The therapeutic efficacy of Clonidine can be decreased when used in combination with Morniflumate.]
[C03XA02, conivaptan, The metabolism of Clonidine can be decreased when combined with Conivaptan.]
[C02AC05, moxonidine, The risk or severity of hypotension can be increased when Clonidine is combined with Moxonidine.]
[J05AF10, entecavir, The metabolism of Clonidine can be decreased when combined with Entecavir.]
[G04BE09, vardenafil, The metabolism of Clonidine can be decreased when combined with Vardenafil.]
[M01AH05, etoricoxib, The metabolism of Clonidine can be decreased when combined with Etoricoxib.]
[L01AX04, dacarbazine, The metabolism of Dacarbazine can be decreased when combined with Clonidine.]
[G03XA01, danazol, The metabolism of Clonidine can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The risk or severity of sedation can be increased when Clonidine is combined with Dantrolene.]
[J04BA02, dapsone, The metabolism of Clonidine can be decreased when combined with Dapsone.]
[L01DB02, daunorubicin, The metabolism of Clonidine can be decreased when combined with Daunorubicin.]
[N06BX04, deanol, The risk or severity of sedation can be increased when Clonidine is combined with Deanol.]
[C02CC04, debrisoquin, The risk or severity of hypotension can be increased when Clonidine is combined with Debrisoquine.]
[A04AD11, nabilone, The risk or severity of sedation can be increased when Clonidine is combined with Nabilone.]
[M01AX01, nabumetone, The therapeutic efficacy of Clonidine can be decreased when used in combination with Nabumetone.]
[N05BA16, nordazepam, The risk or severity of sedation can be increased when Clonidine is combined with Nordazepam.]
[C07AB12, nebivolol, The risk or severity of hypotension can be increased when Clonidine is combined with Nebivolol.]
[N06AX06, nefazodone, The risk or severity of sedation can be increased when Clonidine is combined with Nefazodone.]
[N05CM16, niaprazine, The risk or severity of sedation can be increased when Clonidine is combined with Niaprazine.]
[C01DX16, nicorandil, The risk or severity of hypotension can be increased when Clonidine is combined with Nicorandil.]
[N03AG06, tiagabine, The risk or severity of sedation can be increased when Clonidine is combined with Tiagabine.]
[C01CA23, theodrenaline, The metabolism of Theodrenaline can be decreased when combined with Clonidine.]
[M03AC11, cisatracurium, The risk or severity of sedation can be increased when Clonidine is combined with Cisatracurium.]
[C01CA05, norfenefrine, Norfenefrine may decrease the antihypertensive activities of Clonidine.]
[R05DA06, normethadone, The risk or severity of sedation can be increased when Clonidine is combined with Normethadone.]
[N06AB10, escitalopram, The risk or severity of sedation can be increased when Clonidine is combined with Escitalopram.]
[G04BD08, solifenacin, The metabolism of Clonidine can be decreased when combined with Solifenacin.]
[A07EC03, olsalazine, The therapeutic efficacy of Clonidine can be decreased when used in combination with Olsalazine.]
[N06AA01, desipramine, The risk or severity of sedation can be increased when Clonidine is combined with Desipramine.]
[C01AA07, deslanoside, Clonidine may increase the atrioventricular blocking (AV block) activities of Deslanoside.]
[H01BA02, desmopressin, Desmopressin may decrease the antihypertensive activities of Clonidine.]
[C09XA02, aliskiren, The risk or severity of hypotension can be increased when Clonidine is combined with Aliskiren.]
[M01AE12, oxaprozin, The therapeutic efficacy of Clonidine can be decreased when used in combination with Oxaprozin.]
[N03AF02, oxcarbazepine, The risk or severity of sedation can be increased when Clonidine is combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Clonidine can be increased when combined with Dexamethasone.]
[N06BX07, oxiracetam, The risk or severity of sedation can be increased when Clonidine is combined with Oxiracetam.]
[N04AA08, dexetimide, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, The metabolism of Clonidine can be decreased when combined with Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Clonidine can be decreased when combined with Dexfenfluramine.]
[A03AA01, oxyphencyclimine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[L04AB04, adalimumab, The metabolism of Clonidine can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Clonidine can be decreased when combined with Gefitinib.]
[N06BA02, dextroamphetamine, The metabolism of Clonidine can be decreased when combined with Amphetamine.]
[R05DA09, dextromethorphan, The risk or severity of sedation can be increased when Clonidine is combined with Dextromethorphan.]
[N03AC01, paramethadione, The risk or severity of sedation can be increased when Clonidine is combined with Paramethadione.]
[N02AC01, dextromoramide, The risk or severity of sedation can be increased when Clonidine is combined with Dextromoramide.]
[N06AB05, paroxetine, The risk or severity of sedation can be increased when Clonidine is combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Clonidine can be decreased when combined with Clopidogrel.]
[N07BC06, heroin, The risk or severity of sedation can be increased when Clonidine is combined with Diamorphine.]
[C04AD01, pentifylline, The metabolism of Pentifylline can be decreased when combined with Clonidine.]
[N05BA01, diazepam, The risk or severity of sedation can be increased when Clonidine is combined with Diazepam.]
[N03AX07, phenacemide, The risk or severity of sedation can be increased when Clonidine is combined with Phenacemide.]
[V03AH01, diazoxide, Diazoxide may increase the hypotensive activities of Clonidine.]
[N03AD02, phensuximide, The risk or severity of sedation can be increased when Clonidine is combined with Phensuximide.]
[N06AA08, dibenzepin, The risk or severity of sedation can be increased when Clonidine is combined with Dibenzepin.]
[S02DA04, dibucaine, The risk or severity of sedation can be increased when Clonidine is combined with Cinchocaine.]
[S01EC02, dichlorphenamide, The risk or severity of adverse effects can be increased when Clonidine is combined with Diclofenamide.]
[S01BC03, diclofenac, The therapeutic efficacy of Clonidine can be decreased when used in combination with Diclofenac.]
[J01CF01, dicloxacillin, The metabolism of Clonidine can be increased when combined with Dicloxacillin.]
[A03AA07, dicyclomine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[C02DG01, pinacidil, The risk or severity of hypotension can be increased when Clonidine is combined with Pinacidil.]
[A03AX04, pinaverium, Clonidine may increase the atrioventricular blocking (AV block) activities of Pinaverium.]
[N05AD05, pipamperone, The risk or severity of sedation can be increased when Clonidine is combined with Pipamperone.]
[A03AB14, pipenzolate, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[L01EB02, erlotinib, The metabolism of Clonidine can be decreased when combined with Erlotinib.]
[R03CC07, pirbuterol, Pirbuterol may decrease the antihypertensive activities of Clonidine.]
[A08AA03, diethylpropion, The risk or severity of sedation can be increased when Clonidine is combined with Diethylpropion.]
[L02AA01, diethylstilbestrol, The metabolism of Clonidine can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, Clonidine may increase the atrioventricular blocking (AV block) activities of Isradipine.]
[D07XC04, diflucortolone, The metabolism of Clonidine can be increased when combined with Difluocortolone.]
[A03AB11, poldine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[N02BA11, diflunisal, The therapeutic efficacy of Clonidine can be decreased when used in combination with Diflunisal.]
[C01AA04, digitoxin, Clonidine may increase the atrioventricular blocking (AV block) activities of Digitoxin.]
[C01AA05, digoxin, Clonidine may increase the atrioventricular blocking (AV block) activities of Digoxin.]
[C02DB01, dihydralazine, The risk or severity of hypotension can be increased when Clonidine is combined with Dihydralazine.]
[C04AE04, dihydroergocristine, Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Clonidine.]
[N02CA01, dihydroergotamine, The risk or severity of sedation can be increased when Clonidine is combined with Dihydroergotamine.]
[N02AA03, hydromorphone, The risk or severity of sedation can be increased when Clonidine is combined with Hydromorphone.]
[J05AE08, atazanavir, The metabolism of Clonidine can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The risk or severity of hypotension can be increased when Clonidine is combined with Treprostinil.]
[D04AB07, pramoxine, The risk or severity of sedation can be increased when Clonidine is combined with Pramocaine.]
[C08DB01, diltiazem, Diltiazem may increase the atrioventricular blocking (AV block) activities of Clonidine.]
[R06AA11, dimenhydrinate, The risk or severity of sedation can be increased when Clonidine is combined with Dimenhydrinate.]
[M03BX03, pridinol, The risk or severity of sedation can be increased when Clonidine is combined with Pridinol.]
[R06AB03, dimethindene, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[R03CC08, procaterol, Procaterol may decrease the antihypertensive activities of Clonidine.]
[M02AX03, dimethyl sulfoxide, The metabolism of Clonidine can be decreased when combined with Dimethyl sulfoxide.]
[N03AG05, progabide, The risk or severity of sedation can be increased when Clonidine is combined with Progabide.]
[N06BC02, propentofylline, The metabolism of Propentofylline can be decreased when combined with Clonidine.]
[N02BB04, propyphenazone, The therapeutic efficacy of Clonidine can be decreased when used in combination with Propyphenazone.]
[M01AB14, proglumetacin, The therapeutic efficacy of Clonidine can be decreased when used in combination with Proglumetacin.]
[C05CA03, diosmin, The metabolism of Clonidine can be decreased when combined with Diosmin.]
[R03DA03, proxyphylline, The metabolism of Proxyphylline can be decreased when combined with Clonidine.]
[R06AA02, diphenhydramine, The risk or severity of sedation can be increased when Clonidine is combined with Diphenhydramine.]
[A07DA01, diphenoxylate, The risk or severity of sedation can be increased when Clonidine is combined with Diphenoxylate.]
[N05CD10, quazepam, The risk or severity of sedation can be increased when Clonidine is combined with Quazepam.]
[C09AA06, quinapril, The risk or severity of hypotension can be increased when Clonidine is combined with Quinapril.]
[B01AC07, dipyridamole, Dipyridamole may increase the antihypertensive activities of Clonidine.]
[N06BA11, dexmethylphenidate, The risk or severity of sedation can be increased when Clonidine is combined with Dexmethylphenidate.]
[N06AA23, quinupramine, The risk or severity of sedation can be increased when Clonidine is combined with Quinupramine.]
[A03FA02, cisapride, The risk or severity of sedation can be increased when Clonidine is combined with Cisapride.]
[C09AA05, ramipril, The risk or severity of hypotension can be increased when Clonidine is combined with Ramipril.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Clonidine.]
[N05AL04, remoxipride, The risk or severity of sedation can be increased when Clonidine is combined with Remoxipride.]
[R03CC14, reproterol, Reproterol may decrease the antihypertensive activities of Clonidine.]
[C01BA03, disopyramide, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.]
[P03AA04, disulfiram, The metabolism of Clonidine can be decreased when combined with Disulfiram.]
[S02AA12, rifamycin SV, The metabolism of Clonidine can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Clonidine can be increased when combined with Rifapentine.]
[N07XX02, riluzole, The risk or severity of sedation can be increased when Clonidine is combined with Riluzole.]
[N05AX08, risperidone, The risk or severity of sedation can be increased when Clonidine is combined with Risperidone.]
[R06AE09, levocetirizine, The risk or severity of sedation can be increased when Clonidine is combined with Levocetirizine.]
[N01BB09, ropivacaine, The risk or severity of sedation can be increased when Clonidine is combined with Ropivacaine.]
[J01MB01, rosoxacin, The metabolism of Clonidine can be decreased when combined with Rosoxacin.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Clonidine.]
[A04AD12, aprepitant, The metabolism of Clonidine can be decreased when combined with Aprepitant.]
[L01XG01, bortezomib, The metabolism of Clonidine can be decreased when combined with Bortezomib.]
[J05AE07, fosamprenavir, The metabolism of Clonidine can be decreased when combined with Fosamprenavir.]
[G04BE08, tadalafil, The risk or severity of hypotension can be increased when Clonidine is combined with Tadalafil.]
[S01BC05, ketorolac, The therapeutic efficacy of Clonidine can be decreased when used in combination with Ketorolac.]
[C02KX02, ambrisentan, The risk or severity of hypotension can be increased when Clonidine is combined with Ambrisentan.]
[C01EB18, ranolazine, The serum concentration of Clonidine can be increased when it is combined with Ranolazine.]
[N02BA06, salsalate, The therapeutic efficacy of Clonidine can be decreased when used in combination with Salsalate.]
[R03AC12, salmeterol, The metabolism of Clonidine can be decreased when combined with Salmeterol.]
[C01CA07, dobutamine, Dobutamine may decrease the antihypertensive activities of Clonidine.]
[A03FA03, domperidone, The metabolism of Clonidine can be decreased when combined with Domperidone.]
[C01CA04, dopamine, Dopamine may decrease the antihypertensive activities of Clonidine.]
[N06AA16, dothiepin, The risk or severity of sedation can be increased when Clonidine is combined with Dosulepin.]
[R07AB01, doxapram, Doxapram may decrease the antihypertensive activities of Clonidine.]
[N06AA12, doxepin, The risk or severity of sedation can be increased when Clonidine is combined with Doxepin.]
[L01DB01, doxorubicin, The metabolism of Clonidine can be decreased when combined with Doxorubicin.]
[R06AA09, doxylamine, The risk or severity of sedation can be increased when Clonidine is combined with Doxylamine.]
[N06AB06, sertraline, The risk or severity of sedation can be increased when Clonidine is combined with Sertraline.]
[N01AB08, sevoflurane, The risk or severity of sedation can be increased when Clonidine is combined with Sevoflurane.]
[N05AD08, droperidol, The risk or severity of sedation can be increased when Clonidine is combined with Droperidol.]
[A08AA10, sibutramine, The risk or severity of sedation can be increased when Clonidine is combined with Sibutramine.]
[C10AA01, simvastatin, The metabolism of Clonidine can be decreased when combined with Simvastatin.]
[C09AA11, spirapril, The risk or severity of hypotension can be increased when Clonidine is combined with Spirapril.]
[N05AL02, sultopride, The risk or severity of sedation can be increased when Clonidine is combined with Sultopride.]
[N02CC01, sumatriptan, The risk or severity of sedation can be increased when Clonidine is combined with Sumatriptan.]
[C07AB13, talinolol, The risk or severity of hypotension can be increased when Clonidine is combined with Talinolol.]
[H01AA01, corticotropin, The metabolism of Clonidine can be increased when combined with Corticotropin.]
[J01MA05, temafloxacin, The metabolism of Clonidine can be decreased when combined with Temafloxacin.]
[M01AC02, tenoxicam, The therapeutic efficacy of Clonidine can be decreased when used in combination with Tenoxicam.]
[G04CA03, terazosin, The risk or severity of hypotension can be increased when Clonidine is combined with Terazosin.]
[D01BA02, terbinafine, The metabolism of Clonidine can be decreased when combined with Terbinafine.]
[G04BD05, terodiline, Clonidine may increase the atrioventricular blocking (AV block) activities of Terodiline.]
[C07AA16, tertatolol, The risk or severity of adverse effects can be increased when Clonidine is combined with Tertatolol.]
[S01GA02, tetrahydrozoline, Tetryzoline may decrease the antihypertensive activities of Clonidine.]
[M03BX07, tetrazepam, The risk or severity of sedation can be increased when Clonidine is combined with Tetrazepam.]
[M03BX05, thiocolchicoside, The risk or severity of sedation can be increased when Clonidine is combined with Thiocolchicoside.]
[N05AB05, thiopropazate, The risk or severity of sedation can be increased when Clonidine is combined with Thiopropazate.]
[G04BD01, emepronium, The risk or severity of sedation can be increased when Clonidine is combined with Emepronium.]
[N06AX14, tianeptine, The risk or severity of sedation can be increased when Clonidine is combined with Tianeptine.]
[C09AA02, enalapril, The risk or severity of hypotension can be increased when Clonidine is combined with Enalapril.]
[N05BA23, tofisopam, The risk or severity of sedation can be increased when Clonidine is combined with Tofisopam.]
[M01AG02, tolfenamic acid, The therapeutic efficacy of Clonidine can be decreased when used in combination with Tolfenamic acid.]
[N06AG03, toloxatone, The risk or severity of sedation can be increased when Clonidine is combined with Toloxatone.]
[N06BA09, atomoxetine, The metabolism of Clonidine can be decreased when combined with Atomoxetine.]
[N03AX11, topiramate, The risk or severity of sedation can be increased when Clonidine is combined with Topiramate.]
[C03CA04, torsemide, The risk or severity of hypotension can be increased when Clonidine is combined with Torasemide.]
[R01AA09, tramazoline, Tramazoline may decrease the antihypertensive activities of Clonidine.]
[C09AA10, trandolapril, The risk or severity of hypotension can be increased when Clonidine is combined with Trandolapril.]
[N05CD11, triazulenone, The risk or severity of sedation can be increased when Clonidine is combined with Loprazolam.]
[N05CM07, triclofos, The risk or severity of sedation can be increased when Clonidine is combined with Triclofos.]
[A03AB08, tridihexethyl, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[R06AA10, trimethobenzamide, The risk or severity of sedation can be increased when Clonidine is combined with Trimethobenzamide.]
[N04AA12, tropatepine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[R03CC11, tulobuterol, Tulobuterol may decrease the antihypertensive activities of Clonidine.]
[N01AB04, enflurane, The risk or severity of sedation can be increased when Clonidine is combined with Enflurane.]
[C02CA06, urapidil, The risk or severity of sedation can be increased when Clonidine is combined with Urapidil.]
[J01MA04, enoxacin, The metabolism of Clonidine can be decreased when combined with Enoxacin.]
[N05AL06, veralipride, The risk or severity of sedation can be increased when Clonidine is combined with Veralipride.]
[L01CA04, vinorelbine, The metabolism of Clonidine can be decreased when combined with Vinorelbine.]
[S01FB02, ephedrine, Ephedrine may decrease the antihypertensive activities of Clonidine.]
[S01GX10, epinastine, The risk or severity of sedation can be increased when Clonidine is combined with Epinastine.]
[N06AX16, venlafaxine, The risk or severity of sedation can be increased when Clonidine is combined with Venlafaxine.]
[C01CX07, xamoterol, Xamoterol may decrease the antihypertensive activities of Clonidine.]
[S01GA03, xylometazoline, Clonidine may increase the atrioventricular blocking (AV block) activities of Xylometazoline.]
[C08CA12, mepirodipine, Clonidine may increase the atrioventricular blocking (AV block) activities of Barnidipine.]
[S01EA01, epinephrine, The metabolism of Clonidine can be decreased when combined with Epinephrine.]
[C09AA15, zofenopril, The risk or severity of hypotension can be increased when Clonidine is combined with Zofenopril.]
[N05CF02, zolpidem, The risk or severity of sedation can be increased when Clonidine is combined with Zolpidem.]
[M01AB04, zomepirac, The therapeutic efficacy of Clonidine can be decreased when used in combination with Zomepirac.]
[N03AX15, zonisamide, The risk or severity of sedation can be increased when Clonidine is combined with Zonisamide.]
[A10AB06, insulin glulisine, human, The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Clonidine.]
[N05CF01, zopiclone, The risk or severity of sedation can be increased when Clonidine is combined with Zopiclone.]
[N05AX11, zotepine, The risk or severity of sedation can be increased when Clonidine is combined with Zotepine.]
[C02AC02, guanfacine, The risk or severity of sedation can be increased when Clonidine is combined with Guanfacine.]
[B01AC11, iloprost, Iloprost may increase the hypotensive activities of Clonidine.]
[C01BG01, moricizine, The risk or severity of sedation can be increased when Clonidine is combined with Moricizine.]
[G02AB03, ergonovine, The risk or severity of sedation can be increased when Clonidine is combined with Ergometrine.]
[C04AE01, ergoloid mesylates, USP, The risk or severity of sedation can be increased when Clonidine is combined with Ergoloid mesylate.]
[N02CA02, ergotamine, The risk or severity of sedation can be increased when Clonidine is combined with Ergotamine.]
[S01AA17, erythromycin, The metabolism of Clonidine can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, The risk or severity of sedation can be increased when Clonidine is combined with Estazolam.]
[H05BX01, cinacalcet, The metabolism of Clonidine can be decreased when combined with Cinacalcet.]
[G03CA03, estradiol, The risk or severity of sedation can be increased when Estradiol is combined with Clonidine.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Clonidine can be decreased when combined with Conjugated estrogens.]
[J04AK02, ethambutol, The metabolism of Clonidine can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The metabolism of Clonidine can be increased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Clonidine can be increased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Clonidine can be decreased when combined with Fluvastatin.]
[C01CA15, gepefrine, Gepefrine may decrease the antihypertensive activities of Clonidine.]
[N05CM08, ethchlorvynol, The risk or severity of sedation can be increased when Clonidine is combined with Ethchlorvynol.]
[L02AA03, ethinyl estradiol, The risk or severity of sedation can be increased when Ethinylestradiol is combined with Clonidine.]
[V03AF05, amifostine, Clonidine may increase the hypotensive activities of Amifostine.]
[N04AA05, profenamine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Profenamine.]
[N03AD01, ethosuximide, The risk or severity of sedation can be increased when Clonidine is combined with Ethosuximide.]
[N03AB01, ethotoin, The risk or severity of sedation can be increased when Clonidine is combined with Ethotoin.]
[M01AC06, meloxicam, The therapeutic efficacy of Clonidine can be decreased when used in combination with Meloxicam.]
[S01XA06, ethylmorphine, The risk or severity of sedation can be increased when Clonidine is combined with Ethylmorphine.]
[C01CA01, etilefrine, Etilefrine may decrease the antihypertensive activities of Clonidine.]
[N01AX07, etomidate, The risk or severity of sedation can be increased when Clonidine is combined with Etomidate.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Clonidine.]
[N05AE03, sertindole, The risk or severity of sedation can be increased when Clonidine is combined with Sertindole.]
[L04AD02, tacrolimus, The metabolism of Clonidine can be decreased when combined with Tacrolimus.]
[R06AX11, astemizole, The metabolism of Clonidine can be decreased when combined with Astemizole.]
[R06AX12, terfenadine, The metabolism of Clonidine can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The risk or severity of sedation can be increased when Clonidine is combined with Bupropion.]
[N06AB08, fluvoxamine, The risk or severity of sedation can be increased when Clonidine is combined with Fluvoxamine.]
[C01BB03, tocainide, The metabolism of Clonidine can be decreased when combined with Tocainide.]
[C01BC08, encainide, The metabolism of Clonidine can be decreased when combined with Encainide.]
[A02BA03, famotidine, The metabolism of Clonidine can be decreased when combined with Famotidine.]
[P02CA03, albendazole, The metabolism of Clonidine can be increased when combined with Albendazole.]
[C08CA02, felodipine, Clonidine may increase the atrioventricular blocking (AV block) activities of Felodipine.]
[C08EA01, fendiline, Clonidine may increase the atrioventricular blocking (AV block) activities of Fendiline.]
[N03AX26, fenfluramine, The risk or severity of sedation can be increased when Clonidine is combined with Fenfluramine.]
[M01AE04, fenoprofen, The therapeutic efficacy of Clonidine can be decreased when used in combination with Fenoprofen.]
[R03CC04, fenoterol, Fenoterol may decrease the antihypertensive activities of Clonidine.]
[N02AB03, fentanyl, The risk or severity of sedation can be increased when Clonidine is combined with Fentanyl.]
[R03CC02, albuterol, Salbutamol may decrease the antihypertensive activities of Clonidine.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clonidine is combined with Clofarabine.]
[N07AX03, cevimeline, The metabolism of Clonidine can be decreased when combined with Cevimeline.]
[G04BD02, flavoxate, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[C01BC04, flecainide, The metabolism of Clonidine can be decreased when combined with Flecainide.]
[N02BG04, floctafenine, The therapeutic efficacy of Clonidine can be decreased when used in combination with Floctafenine.]
[J01CF05, floxacillin, The metabolism of Clonidine can be increased when combined with Flucloxacillin.]
[J02AC01, fluconazole, The metabolism of Clonidine can be decreased when combined with Fluconazole.]
[N07CA03, flunarizine, The risk or severity of sedation can be increased when Clonidine is combined with Flunarizine.]
[N05CD03, flunitrazepam, The risk or severity of sedation can be increased when Clonidine is combined with Flunitrazepam.]
[D07AC08, fluocinonide, The metabolism of Clonidine can be increased when combined with Fluocinonide.]
[N06AA14, melitracen, The risk or severity of sedation can be increased when Clonidine is combined with Melitracen.]
[H02AB03, fluocortolone, The metabolism of Clonidine can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, Ethanol may increase the central nervous system depressant (CNS depressant) activities of Clonidine.]
[L01BC02, fluorouracil, The metabolism of Clonidine can be decreased when combined with Fluorouracil.]
[N06AB03, fluoxetine, The risk or severity of sedation can be increased when Clonidine is combined with Fluoxetine.]
[N05AF01, flupenthixol, The risk or severity of sedation can be increased when Clonidine is combined with Flupentixol.]
[N05AB02, fluphenazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Clonidine.]
[N05CD01, flurazepam, The risk or severity of sedation can be increased when Clonidine is combined with Flurazepam.]
[S01BC04, flurbiprofen, The therapeutic efficacy of Clonidine can be decreased when used in combination with Flurbiprofen.]
[N05AG01, fluspirilene, The risk or severity of sedation can be increased when Clonidine is combined with Fluspirilene.]
[L02BB01, flutamide, The metabolism of Clonidine can be decreased when combined with Flutamide.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Clonidine.]
[N06BX17, adrafinil, Adrafinil may decrease the antihypertensive activities of Clonidine.]
[M03AA01, alcuronium, The risk or severity of sedation can be increased when Clonidine is combined with Alcuronium.]
[G01AX06, furazolidone, The risk or severity of sedation can be increased when Clonidine is combined with Furazolidone.]
[J05AE10, darunavir, The serum concentration of Clonidine can be increased when it is combined with Darunavir.]
[C03CA01, furosemide, The risk or severity of hypotension can be increased when Clonidine is combined with Furosemide.]
[N05CF04, eszopiclone, The risk or severity of sedation can be increased when Clonidine is combined with Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of sedation can be increased when Clonidine is combined with Amisulpride.]
[N06DA04, galantamine, The metabolism of Clonidine can be decreased when combined with Galantamine.]
[M03AC02, gallamine, The risk or severity of sedation can be increased when Clonidine is combined with Gallamine.]
[C08DA02, gallopamil, Clonidine may increase the atrioventricular blocking (AV block) activities of Gallopamil.]
[N03AA04, barbexaclone, The risk or severity of sedation can be increased when Clonidine is combined with Barbexaclone.]
[N06AX08, bifemelane, The risk or severity of sedation can be increased when Clonidine is combined with Bifemelane.]
[C10AB04, gemfibrozil, The metabolism of Clonidine can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, The metabolism of Clonidine can be decreased when combined with Dasatinib.]
[N04BC06, cabergoline, The risk or severity of sedation can be increased when Clonidine is combined with Cabergoline.]
[C01CA21, cafedrine, The metabolism of Cafedrine can be decreased when combined with Clonidine.]
[J05AG04, etravirine, The metabolism of Clonidine can be increased when combined with Etravirine.]
[N03AD03, methsuximide, The risk or severity of sedation can be increased when Clonidine is combined with Methsuximide.]
[G03XA02, gestrinone, The risk or severity of sedation can be increased when Gestrinone is combined with Clonidine.]
[N01AH02, alfentanil, The risk or severity of sedation can be increased when Clonidine is combined with Alfentanil.]
[L01EH01, lapatinib, The metabolism of Clonidine can be decreased when combined with Lapatinib.]
[A10BB01, glyburide, The metabolism of Clonidine can be decreased when combined with Glyburide.]
[N05CM18, dexmedetomidine, The risk or severity of sedation can be increased when Clonidine is combined with Dexmedetomidine.]
[N05CE01, glutethimide, The risk or severity of sedation can be increased when Clonidine is combined with Glutethimide.]
[C05AE01, nitroglycerin, The risk or severity of hypotension can be increased when Clonidine is combined with Nitroglycerin.]
[C02CA04, doxazosin, The risk or severity of hypotension can be increased when Clonidine is combined with Doxazosin.]
[L01EX02, sorafenib, The metabolism of Clonidine can be decreased when combined with Sorafenib.]
[C07AB09, esmolol, The risk or severity of hypotension can be increased when Clonidine is combined with Esmolol.]
[C09AA09, fosinopril, The risk or severity of hypotension can be increased when Clonidine is combined with Fosinopril.]
[D01BA01, griseofulvin, The metabolism of Clonidine can be increased when combined with Griseofulvin.]
[S01EX01, guanethidine, The risk or severity of hypotension can be increased when Clonidine is combined with Guanethidine.]
[P01BX01, halofantrine, The metabolism of Clonidine can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The risk or severity of sedation can be increased when Clonidine is combined with Haloperidol.]
[N01AB01, halothane, The risk or severity of sedation can be increased when Clonidine is combined with Halothane.]
[N05AH04, quetiapine, The risk or severity of sedation can be increased when Clonidine is combined with Quetiapine.]
[A10AD05, insulin aspart, human, The therapeutic efficacy of Insulin aspart can be increased when used in combination with Clonidine.]
[N02CX03, iprazochrome, The risk or severity of sedation can be increased when Clonidine is combined with Iprazochrome.]
[L01CE02, irinotecan, The metabolism of Clonidine can be decreased when combined with Irinotecan.]
[N05CA21, allobarbital, The risk or severity of sedation can be increased when Clonidine is combined with Allobarbital.]
[C09CA01, losartan, The risk or severity of hypotension can be increased when Clonidine is combined with Losartan.]
[G03DC01, allylestrenol, The metabolism of Clonidine can be decreased when combined with Allylestrenol.]
[A07EC02, mesalamine, The therapeutic efficacy of Clonidine can be decreased when used in combination with Mesalazine.]
[N05CA16, hexobarbital, The risk or severity of sedation can be increased when Clonidine is combined with Hexobarbital.]
[R03CC05, hexoprenaline, Hexoprenaline may decrease the antihypertensive activities of Clonidine.]
[J05AG01, nevirapine, The metabolism of Clonidine can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, Clonidine may increase the atrioventricular blocking (AV block) activities of Nilvadipine.]
[M02AA26, nimesulide, Clonidine may increase the atrioventricular blocking (AV block) activities of Nimesulide.]
[C09AA04, perindopril, The risk or severity of hypotension can be increased when Clonidine is combined with Perindopril.]
[C02DB02, hydralazine, The risk or severity of hypotension can be increased when Clonidine is combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, The risk or severity of hypotension can be increased when Clonidine is combined with Hydrochlorothiazide.]
[R05DA03, hydrocodone, The risk or severity of sedation can be increased when Clonidine is combined with Hydrocodone.]
[S02BA01, hydrocortisone, The metabolism of Clonidine can be increased when combined with Hydrocortisone.]
[C03AA02, hydroflumethiazide, The risk or severity of hypotension can be increased when Clonidine is combined with Hydroflumethiazide.]
[G04BD06, propiverine, The therapeutic efficacy of Clonidine can be decreased when used in combination with Propiverine.]
[P01BA02, hydroxychloroquine, The metabolism of Clonidine can be decreased when combined with Hydroxychloroquine.]
[N05AX07, prothipendyl, The risk or severity of sedation can be increased when Clonidine is combined with Prothipendyl.]
[N05BB01, hydroxyzine, The risk or severity of sedation can be increased when Clonidine is combined with Hydroxyzine.]
[J04AB04, rifabutin, The metabolism of Clonidine can be increased when combined with Rifabutin.]
[C02AC06, rilmenidine, The risk or severity of hypotension can be increased when Clonidine is combined with Rilmenidine.]
[R02AX02, ibuprofen, The therapeutic efficacy of Clonidine can be decreased when used in combination with Ibuprofen.]
[L01DB06, idarubicin, The metabolism of Clonidine can be decreased when combined with Idarubicin.]
[L01AA06, ifosfamide, The metabolism of Clonidine can be increased when combined with Ifosfamide.]
[H01AC02, somatrem, The metabolism of Clonidine can be increased when combined with Somatrem.]
[N01AH03, sufentanil, The risk or severity of sedation can be increased when Clonidine is combined with Sufentanil.]
[N06AA02, imipramine, The risk or severity of sedation can be increased when Clonidine is combined with Imipramine.]
[L01CD01, paclitaxel, The metabolism of Clonidine can be increased when combined with Paclitaxel.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Tizanidine is combined with Clonidine.]
[C03BA11, indapamide, The risk or severity of hypotension can be increased when Clonidine is combined with Indapamide.]
[S01BC01, indomethacin, The therapeutic efficacy of Clonidine can be decreased when used in combination with Indomethacin.]
[C02CA02, indoramin, The risk or severity of hypotension can be increased when Clonidine is combined with Indoramin.]
[L03AB04, interferon alfa-2a, The metabolism of Clonidine can be decreased when combined with Interferon alfa-2a.]
[L03AB05, interferon alfa-2b, The metabolism of Clonidine can be decreased when combined with Interferon alfa-2b.]
[N06AX17, milnacipran, The risk or severity of sedation can be increased when Clonidine is combined with Milnacipran.]
[A03AA30, piperidolate, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[N01BB08, articaine, The risk or severity of sedation can be increased when Clonidine is combined with Articaine.]
[N05BA12, alprazolam, The risk or severity of sedation can be increased when Clonidine is combined with Alprazolam.]
[N05CH02, ramelteon, The risk or severity of sedation can be increased when Clonidine is combined with Ramelteon.]
[R06AE01, buclizine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[C10AA06, cerivastatin, The metabolism of Clonidine can be increased when combined with Cerivastatin.]
[L01XX35, anagrelide, The metabolism of Clonidine can be decreased when combined with Anagrelide.]
[C07AA01, alprenolol, The risk or severity of sedation can be increased when Clonidine is combined with Alprenolol.]
[L03AB09, interferon alfacon-1, The metabolism of Clonidine can be decreased when combined with Interferon alfacon-1.]
[V03AB01, ipecac, The metabolism of Clonidine can be decreased when combined with Ipecac.]
[N06AA13, iprindole, The risk or severity of sedation can be increased when Clonidine is combined with Iprindole.]
[N06AF05, iproniazid, The risk or severity of sedation can be increased when Clonidine is combined with Iproniazid.]
[J05AB13, penciclovir, The metabolism of Clonidine can be decreased when combined with Penciclovir.]
[N05AA07, chlorproethazine, The risk or severity of sedation can be increased when Clonidine is combined with Chlorproethazine.]
[N06AF01, isocarboxazid, The risk or severity of sedation can be increased when Clonidine is combined with Isocarboxazid.]
[S01EC03, dorzolamide, Clonidine may increase the hypotensive activities of Dorzolamide.]
[R03CC06, isoetharine, Isoetharine may decrease the antihypertensive activities of Clonidine.]
[C09AA16, imidapril, The risk or severity of hypotension can be increased when Clonidine is combined with Imidapril.]
[N01AB06, isoflurane, The risk or severity of sedation can be increased when Clonidine is combined with Isoflurane.]
[N04BX02, entacapone, The risk or severity of sedation can be increased when Clonidine is combined with Entacapone.]
[J04AC01, isoniazid, The metabolism of Clonidine can be decreased when combined with Isoniazid.]
[R03CB01, isoproterenol, Isoprenaline may decrease the antihypertensive activities of Clonidine.]
[C01DA14, isosorbide mononitrate, The risk or severity of adverse effects can be increased when Clonidine is combined with Isosorbide mononitrate.]
[C05AE02, isosorbide dinitrate, The risk or severity of adverse effects can be increased when Clonidine is combined with Isosorbide dinitrate.]
[C04AA01, isoxsuprine, Isoxsuprine may decrease the antihypertensive activities of Clonidine.]
[N06AX18, reboxetine, The risk or severity of sedation can be increased when Clonidine is combined with Reboxetine.]
[H01AC01, somatropin, The metabolism of Clonidine can be increased when combined with Somatotropin.]
[L04AC07, tocilizumab, The metabolism of Clonidine can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The risk or severity of sedation can be increased when Clonidine is combined with Ketamine.]
[C02KD01, ketanserin, The risk or severity of sedation can be increased when Clonidine is combined with Ketanserin.]
[J02AB02, ketoconazole, The metabolism of Clonidine can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, The risk or severity of sedation can be increased when Clonidine is combined with Olanzapine.]
[M02AA10, ketoprofen, The therapeutic efficacy of Clonidine can be decreased when used in combination with Ketoprofen.]
[V03AC03, deferasirox, The serum concentration of Clonidine can be increased when it is combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Clonidine can be increased when combined with Abatacept.]
[C01CA22, arbutamine, Arbutamine may decrease the antihypertensive activities of Clonidine.]
[N04BC09, rotigotine, The risk or severity of sedation can be increased when Clonidine is combined with Rotigotine.]
[J01MB02, nalidixic acid, The metabolism of Clonidine can be decreased when combined with Nalidixic acid.]
[M01AE11, tiaprofenic acid, The therapeutic efficacy of Clonidine can be decreased when used in combination with Tiaprofenic acid.]
[C07AG01, labetalol, The risk or severity of hypotension can be increased when Clonidine is combined with Labetalol.]
[C02AA05, deserpidine, The risk or severity of hypotension can be increased when Clonidine is combined with Deserpidine.]
[N03AX18, lacosamide, The risk or severity of sedation can be increased when Clonidine is combined with Lacosamide.]
[C03CC01, ethacrynic acid, The risk or severity of adverse effects can be increased when Clonidine is combined with Etacrynic acid.]
[G03AD01, levonorgestrel, The risk or severity of sedation can be increased when Levonorgestrel is combined with Clonidine.]
[N04BA01, levodopa, The risk or severity of sedation can be increased when Clonidine is combined with Levodopa.]
[S02DA01, lidocaine, The risk or severity of sedation can be increased when Clonidine is combined with Lidocaine.]
[C08EX01, lidoflazine, Clonidine may increase the atrioventricular blocking (AV block) activities of Lidoflazine.]
[N06BA13, armodafinil, The metabolism of Clonidine can be increased when combined with Armodafinil.]
[C03DB01, amiloride, The risk or severity of adverse effects can be increased when Clonidine is combined with Amiloride.]
[N02CA07, lisuride, The risk or severity of sedation can be increased when Clonidine is combined with Lisuride.]
[N06AA07, lofepramine, The risk or severity of sedation can be increased when Clonidine is combined with Lofepramine.]
[A07DA03, loperamide, Clonidine may increase the atrioventricular blocking (AV block) activities of Loperamide.]
[N05BA06, lorazepam, The risk or severity of sedation can be increased when Clonidine is combined with Lorazepam.]
[C10AA02, lovastatin, The metabolism of Clonidine can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, The risk or severity of sedation can be increased when Clonidine is combined with Loxapine.]
[G03DC03, lynestrenol, The risk or severity of sedation can be increased when Lynestrenol is combined with Clonidine.]
[L01EG01, temsirolimus, The metabolism of Clonidine can be decreased when combined with Temsirolimus.]
[V04CC02, magnesium sulfate, The risk or severity of sedation can be increased when Clonidine is combined with Magnesium sulfate.]
[L01EA03, nilotinib, The metabolism of Clonidine can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, The risk or severity of adverse effects can be increased when Clonidine is combined with Mannitol.]
[N06AA21, maprotiline, The risk or severity of sedation can be increased when Clonidine is combined with Maprotiline.]
[A08AA05, mazindol, The risk or severity of sedation can be increased when Clonidine is combined with Mazindol.]
[C02BB01, mecamylamine, The risk or severity of hypotension can be increased when Clonidine is combined with Mecamylamine.]
[R06AE05, meclizine, The risk or severity of sedation can be increased when Clonidine is combined with Meclizine.]
[M02AA18, meclofenamic acid, The therapeutic efficacy of Clonidine can be decreased when used in combination with Meclofenamic acid.]
[N05BA03, medazepam, The risk or severity of sedation can be increased when Clonidine is combined with Medazepam.]
[C01AA08, medigoxin, Clonidine may increase the atrioventricular blocking (AV block) activities of Metildigoxin.]
[N05CH01, melatonin, The risk or severity of sedation can be increased when Clonidine is combined with Melatonin.]
[N02AB02, meperidine, The risk or severity of sedation can be increased when Clonidine is combined with Meperidine.]
[C01CA11, mephentermine, Mephentermine may decrease the antihypertensive activities of Clonidine.]
[N03AB04, mephenytoin, The risk or severity of sedation can be increased when Clonidine is combined with Mephenytoin.]
[N03AA01, mephobarbital, The risk or severity of sedation can be increased when Clonidine is combined with Methylphenobarbital.]
[N01BB03, mepivacaine, The risk or severity of sedation can be increased when Clonidine is combined with Mepivacaine.]
[N05BC01, meprobamate, The risk or severity of sedation can be increased when Clonidine is combined with Meprobamate.]
[N02AX05, meptazinol, The risk or severity of sedation can be increased when Clonidine is combined with Meptazinol.]
[L02BG01, aminoglutethimide, The metabolism of Clonidine can be increased when combined with Aminoglutethimide.]
[N05AC03, mesoridazine, The risk or severity of sedation can be increased when Clonidine is combined with Mesoridazine.]
[N05AX13, paliperidone, The risk or severity of sedation can be increased when Clonidine is combined with Paliperidone.]
[C01CA09, metaraminol, Metaraminol may decrease the antihypertensive activities of Clonidine.]
[A04AA04, dolasetron, The risk or severity of sedation can be increased when Clonidine is combined with Dolasetron.]
[H01CB03, lanreotide, The metabolism of Clonidine can be decreased when combined with Lanreotide.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Clonidine.]
[N06BA03, methamphetamine, The risk or severity of sedation can be increased when Clonidine is combined with Metamfetamine.]
[A03AB07, methantheline, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, The risk or severity of sedation can be increased when Clonidine is combined with Methapyrilene.]
[N05CM01, methaqualone, The risk or severity of sedation can be increased when Clonidine is combined with Methaqualone.]
[N03AA30, metharbital, The risk or severity of sedation can be increased when Clonidine is combined with Metharbital.]
[S01EC05, methazolamide, The risk or severity of adverse effects can be increased when Clonidine is combined with Methazolamide.]
[G02CB05, metergoline, The risk or severity of sedation can be increased when Clonidine is combined with Metergoline.]
[H03BB02, methimazole, The metabolism of Clonidine can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, The metabolism of Pemetrexed can be decreased when combined with Clonidine.]
[M03BA03, methocarbamol, The risk or severity of sedation can be increased when Clonidine is combined with Methocarbamol.]
[N05CA15, methohexital, The risk or severity of sedation can be increased when Clonidine is combined with Methohexital.]
[N02BG08, ziconotide, The risk or severity of sedation can be increased when Clonidine is combined with Ziconotide.]
[N05AA02, methotrimeprazine, The risk or severity of sedation can be increased when Clonidine is combined with Methotrimeprazine.]
[C01CA10, methoxamine, Methoxamine may decrease the antihypertensive activities of Clonidine.]
[D05BA02, methoxsalen, The metabolism of Clonidine can be decreased when combined with Methoxsalen.]
[N02BG09, methoxyflurane, The risk or severity of sedation can be increased when Clonidine is combined with Methoxyflurane.]
[C03AA08, methyclothiazide, The therapeutic efficacy of Clonidine can be increased when used in combination with Methyclothiazide.]
[C02AB01, methyldopa, The risk or severity of hypotension can be increased when Clonidine is combined with Methyldopa.]
[V04CG05, methylene blue, The risk or severity of sedation can be increased when Clonidine is combined with Methylene blue.]
[G02AB01, methylergonovine, The metabolism of Clonidine can be decreased when combined with Methylergometrine.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Clonidine.]
[N06BA04, methylphenidate, The risk or severity of adverse effects can be increased when Methylphenidate is combined with Clonidine.]
[H02AB04, methylprednisolone, The metabolism of Clonidine can be increased when combined with Methylprednisolone.]
[N03AF03, rufinamide, The risk or severity of sedation can be increased when Clonidine is combined with Rufinamide.]
[N05CE02, methyprylon, The risk or severity of sedation can be increased when Clonidine is combined with Methyprylon.]
[N02CA04, methysergide, The risk or severity of sedation can be increased when Clonidine is combined with Methysergide.]
[A03FA01, metoclopramide, The risk or severity of sedation can be increased when Metoclopramide is combined with Clonidine.]
[C03BA08, metolazone, The risk or severity of hypotension can be increased when Clonidine is combined with Metolazone.]
[C07AB02, metoprolol, The risk or severity of hypotension can be increased when Clonidine is combined with Metoprolol.]
[P01AB01, metronidazole, The metabolism of Clonidine can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Clonidine can be increased when combined with Metyrapone.]
[C01BB02, mexiletine, The metabolism of Clonidine can be decreased when combined with Mexiletine.]
[N06AX03, mianserin, The risk or severity of sedation can be increased when Clonidine is combined with Mianserin.]
[S02AA13, miconazole, The metabolism of Clonidine can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Clonidine can be decreased when combined with Aminophenazone.]
[N05CD08, midazolam, The risk or severity of sedation can be increased when Clonidine is combined with Midazolam.]
[C01CA17, midodrine, Midodrine may decrease the antihypertensive activities of Clonidine.]
[G03XB01, mifepristone, The risk or severity of sedation can be increased when Mifepristone is combined with Clonidine.]
[C09CA03, valsartan, The risk or severity of hypotension can be increased when Clonidine is combined with Valsartan.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Clonidine.]
[D11AX01, minoxidil, The risk or severity of hypotension can be increased when Clonidine is combined with Minoxidil.]
[J01FA11, miocamycin, The metabolism of Clonidine can be decreased when combined with Miocamycin.]
[L01XX23, mitotane, The metabolism of Clonidine can be increased when combined with Mitotane.]
[N06BA12, lisdexamfetamine, The metabolism of Clonidine can be decreased when combined with Lisdexamfetamine.]
[N05AE02, molindone, The risk or severity of sedation can be increased when Clonidine is combined with Molindone.]
[L03AC01, aldesleukin, The metabolism of Clonidine can be decreased when combined with Aldesleukin.]
[C01DX12, molsidomine, Molsidomine may increase the hypotensive activities of Clonidine.]
[C01BD01, amiodarone, Clonidine may increase the atrioventricular blocking (AV block) activities of Amiodarone.]
[N06AA09, amitriptyline, The risk or severity of sedation can be increased when Clonidine is combined with Amitriptyline.]
[N02AA01, morphine, The risk or severity of sedation can be increased when Clonidine is combined with Morphine.]
[A04AA05, palonosetron, The risk or severity of sedation can be increased when Clonidine is combined with Palonosetron.]
[L04AB05, certolizumab pegol, The metabolism of Clonidine can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be decreased when combined with Clonidine.]
[L01EX03, pazopanib, The metabolism of Clonidine can be decreased when combined with Pazopanib.]
[M03AC03, vecuronium, The risk or severity of sedation can be increased when Clonidine is combined with Vecuronium.]
[N05CA02, amobarbital, The risk or severity of sedation can be increased when Clonidine is combined with Amobarbital.]
[G04CA04, silodosin, The risk or severity of orthostatic hypotension and dizziness can be increased when Clonidine is combined with Silodosin.]
[G03XC01, raloxifene, The metabolism of Clonidine can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, The risk or severity of sedation can be increased when Clonidine is combined with Amoxapine.]
[N03AB05, fosphenytoin, The risk or severity of sedation can be increased when Clonidine is combined with Fosphenytoin.]
[L03AB08, interferon beta-1b, The metabolism of Clonidine can be decreased when combined with Interferon beta-1b.]
[C07AA12, nadolol, The risk or severity of hypotension can be increased when Clonidine is combined with Nadolol.]
[N04BC04, ropinirole, Clonidine may increase the sedative activities of Ropinirole.]
[J01CF06, nafcillin, The metabolism of Clonidine can be increased when combined with Nafcillin.]
[C04AX21, nafronyl, The risk or severity of sedation can be increased when Clonidine is combined with Naftidrofuryl.]
[N02AF02, nalbuphine, The risk or severity of sedation can be increased when Clonidine is combined with Nalbuphine.]
[V03AB15, naloxone, The metabolism of Clonidine can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The risk or severity of hypotension can be increased when Naltrexone is combined with Clonidine.]
[L04AC03, anakinra, The metabolism of Clonidine can be increased when combined with Anakinra.]
[S01GA01, naphazoline, Naphazoline may decrease the antihypertensive activities of Clonidine.]
[N06BA01, amphetamine, The metabolism of Clonidine can be decreased when combined with Amphetamine.]
[M02AA12, naproxen, The therapeutic efficacy of Clonidine can be decreased when used in combination with Naproxen.]
[A10BG01, troglitazone, The metabolism of Clonidine can be increased when combined with Troglitazone.]
[N06AX21, duloxetine, The risk or severity of sedation can be increased when Clonidine is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of sedation can be increased when Clonidine is combined with Tolcapone.]
[L01CD02, docetaxel, The metabolism of Clonidine can be decreased when combined with Docetaxel.]
[N01AH06, remifentanil, The risk or severity of sedation can be increased when Clonidine is combined with Remifentanil.]
[C01CX08, levosimendan, The risk or severity of adverse effects can be increased when Clonidine is combined with Levosimendan.]
[N05AX14, iloperidone, The risk or severity of sedation can be increased when Clonidine is combined with Iloperidone.]
[J02AA01, amphotericin B, The risk or severity of adverse effects can be increased when Clonidine is combined with Amphotericin B.]
[N06AX23, desvenlafaxine, The risk or severity of sedation can be increased when Clonidine is combined with Desvenlafaxine.]
[C09CA07, telmisartan, The risk or severity of hypotension can be increased when Clonidine is combined with Telmisartan.]
[C10AD02, niacin, The metabolism of Clonidine can be decreased when combined with Niacin.]
[N06AF02, nialamide, The risk or severity of sedation can be increased when Clonidine is combined with Nialamide.]
[C08CA04, nicardipine, Clonidine may increase the atrioventricular blocking (AV block) activities of Nicardipine.]
[C04AE02, nicergoline, The metabolism of Clonidine can be decreased when combined with Nicergoline.]
[P02DA01, niclosamide, The metabolism of Clonidine can be decreased when combined with Niclosamide.]
[N07BA01, nicotine, The risk or severity of Tachycardia can be increased when Nicotine is combined with Clonidine.]
[C08CA05, nifedipine, Clonidine may increase the atrioventricular blocking (AV block) activities of Nifedipine.]
[M02AA17, niflumic acid, The therapeutic efficacy of Clonidine can be decreased when used in combination with Niflumic acid.]
[V03AB22, amyl nitrite, The risk or severity of adverse effects can be increased when Clonidine is combined with Amyl Nitrite.]
[C08CA06, nimodipine, Clonidine may increase the atrioventricular blocking (AV block) activities of Nimodipine.]
[C08CA07, nisoldipine, Clonidine may increase the atrioventricular blocking (AV block) activities of Nisoldipine.]
[N05CD02, nitrazepam, The risk or severity of sedation can be increased when Clonidine is combined with Nitrazepam.]
[C08CA08, nitrendipine, Clonidine may increase the atrioventricular blocking (AV block) activities of Nitrendipine.]
[R07AX01, nitric oxide, The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Clonidine.]
[N05CF03, zaleplon, The risk or severity of sedation can be increased when Clonidine is combined with Zaleplon.]
[N04BC05, pramipexole, Clonidine may increase the sedative activities of Pramipexole.]
[C02DD01, nitroprusside, The risk or severity of hypotension can be increased when Clonidine is combined with Nitroprusside.]
[N01AX13, nitrous oxide, The risk or severity of sedation can be increased when Clonidine is combined with Nitrous oxide.]
[N06AX04, nomifensine, The risk or severity of sedation can be increased when Clonidine is combined with Nomifensine.]
[C01CA03, norepinephrine, Norepinephrine may decrease the antihypertensive activities of Clonidine.]
[G03DC02, norethindrone, The risk or severity of sedation can be increased when Norethisterone is combined with Clonidine.]
[S01AE02, norfloxacin, The metabolism of Clonidine can be decreased when combined with Norfloxacin.]
[G03AC07, norgestrienone, The risk or severity of sedation can be increased when Norgestrienone is combined with Clonidine.]
[C02KX01, bosentan, The risk or severity of hypotension can be increased when Clonidine is combined with Bosentan.]
[N06AA10, nortriptyline, The risk or severity of sedation can be increased when Clonidine is combined with Nortriptyline.]
[R05DA07, noscapine, The metabolism of Clonidine can be decreased when combined with Noscapine.]
[L03AB07, interferon beta-1a, The metabolism of Clonidine can be decreased when combined with Interferon beta-1a.]
[G02CA02, nylidrin, Clonidine may increase the atrioventricular blocking (AV block) activities of Nylidrin.]
[H01CB02, octreotide, The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Clonidine.]
[J01FA05, oleandomycin, The metabolism of Clonidine can be decreased when combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Clonidine can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Clonidine can be increased when combined with Omeprazole.]
[N06AA05, opipramol, The risk or severity of sedation can be increased when Clonidine is combined with Opipramol.]
[N02AA02, opium, The risk or severity of sedation can be increased when Clonidine is combined with Opium.]
[R03CB03, metaproterenol, Orciprenaline may decrease the antihypertensive activities of Clonidine.]
[G04CA02, tamsulosin, The metabolism of Clonidine can be decreased when combined with Tamsulosin.]
[C01AC01, ouabain, Clonidine may increase the atrioventricular blocking (AV block) activities of Ouabain.]
[P02BA02, oxamniquine, The metabolism of Clonidine can be decreased when combined with Oxamniquine.]
[N05BA04, oxazepam, The risk or severity of sedation can be increased when Clonidine is combined with Oxazepam.]
[C07AA02, oxprenolol, The risk or severity of sedation can be increased when Clonidine is combined with Oxprenolol.]
[N02AA05, oxycodone, The risk or severity of sedation can be increased when Clonidine is combined with Oxycodone.]
[C01DX03, oxyfedrine, Oxyfedrine may decrease the antihypertensive activities of Clonidine.]
[S01GA04, oxymetazoline, The therapeutic efficacy of Clonidine can be decreased when used in combination with Oxymetazoline.]
[N02AA11, oxymorphone, The risk or severity of sedation can be increased when Clonidine is combined with Oxymorphone.]
[N05AE01, oxypertine, The risk or severity of sedation can be increased when Clonidine is combined with Oxypertine.]
[S01BC02, oxyphenbutazone, The therapeutic efficacy of Clonidine can be decreased when used in combination with Oxyphenbutazone.]
[A03AB03, oxyphenonium, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[N05AH05, asenapine, The risk or severity of sedation can be increased when Clonidine is combined with Asenapine.]
[N02AX06, tapentadol, The risk or severity of sedation can be increased when Clonidine is combined with Tapentadol.]
[M03AC01, pancuronium, The risk or severity of sedation can be increased when Clonidine is combined with Pancuronium.]
[G03DB06, chlormadinone, The risk or severity of sedation can be increased when Chlormadinone is combined with Clonidine.]
[G04BE02, papaverine, The risk or severity of adverse effects can be increased when Clonidine is combined with Papaverine.]
[N05CC05, paraldehyde, The risk or severity of sedation can be increased when Clonidine is combined with Paraldehyde.]
[H02AB05, paramethasone, The metabolism of Clonidine can be increased when combined with Paramethasone.]
[C02KC01, pargyline, The risk or severity of sedation can be increased when Clonidine is combined with Pargyline.]
[J01MA03, pefloxacin, The metabolism of Clonidine can be decreased when combined with Pefloxacin.]
[G04BD11, fesoterodine, The metabolism of Clonidine can be decreased when combined with Fesoterodine.]
[C07AA23, penbutolol, The risk or severity of sedation can be increased when Clonidine is combined with Penbutolol.]
[N05AG03, penfluridol, The risk or severity of sedation can be increased when Clonidine is combined with Penfluridol.]
[N02AD01, pentazocine, The risk or severity of sedation can be increased when Clonidine is combined with Pentazocine.]
[N05CA01, pentobarbital, The risk or severity of sedation can be increased when Clonidine is combined with Pentobarbital.]
[C04AD03, pentoxifylline, Pentoxifylline may increase the hypotensive activities of Clonidine.]
[N05AB10, perazine, The risk or severity of sedation can be increased when Clonidine is combined with Perazine.]
[N04BC02, pergolide, The risk or severity of sedation can be increased when Clonidine is combined with Pergolide.]
[C08EX02, perhexiline, Clonidine may increase the atrioventricular blocking (AV block) activities of Perhexiline.]
[N05AB03, perphenazine, The risk or severity of sedation can be increased when Clonidine is combined with Perphenazine.]
[N02BE03, phenacetin, The metabolism of Clonidine can be decreased when combined with Phenacetin.]
[N02AD02, phenazocine, The risk or severity of sedation can be increased when Clonidine is combined with Phenazocine.]
[N06AF03, phenelzine, The risk or severity of sedation can be increased when Clonidine is combined with Phenelzine.]
[A10BA01, phenformin, The metabolism of Clonidine can be decreased when combined with Phenformin.]
[N03AA02, phenobarbital, The risk or severity of sedation can be increased when Clonidine is combined with Phenobarbital.]
[N01AH04, phenoperidine, The risk or severity of sedation can be increased when Clonidine is combined with Phenoperidine.]
[C04AX02, phenoxybenzamine, The risk or severity of hypotension can be increased when Clonidine is combined with Phenoxybenzamine.]
[A08AA01, phentermine, Phentermine may decrease the antihypertensive activities of Clonidine.]
[V03AB36, phentolamine, The risk or severity of hypotension can be increased when Clonidine is combined with Phentolamine.]
[M02AA01, phenylbutazone, The metabolism of Clonidine can be increased when combined with Phenylbutazone.]
[S01GA05, phenylephrine, The metabolism of Clonidine can be increased when combined with Phenylephrine.]
[R01BA01, phenylpropanolamine, Phenylpropanolamine may decrease the antihypertensive activities of Clonidine.]
[N03AB02, phenytoin, The risk or severity of sedation can be increased when Clonidine is combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Clonidine can be increased when combined with Golimumab.]
[L02BB03, bicalutamide, The metabolism of Clonidine can be decreased when combined with Bicalutamide.]
[C08CX01, mibefradil, Clonidine may increase the atrioventricular blocking (AV block) activities of Mibefradil.]
[N05AG02, pimozide, The risk or severity of sedation can be increased when Clonidine is combined with Pimozide.]
[C07AA03, pindolol, The risk or severity of sedation can be increased when Clonidine is combined with Pindolol.]
[C10AA05, atorvastatin, The metabolism of Clonidine can be decreased when combined with Atorvastatin.]
[J05AE01, saquinavir, The metabolism of Clonidine can be decreased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Clonidine can be decreased when combined with Piperazine.]
[N05AC04, pipothiazine, The risk or severity of sedation can be increased when Clonidine is combined with Pipotiazine.]
[C09CA02, eprosartan, The risk or severity of hypotension can be increased when Clonidine is combined with Eprosartan.]
[A02BX03, pirenzepine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N02AC03, pirinitramide, The risk or severity of sedation can be increased when Clonidine is combined with Piritramide.]
[S01BC06, piroxicam, The therapeutic efficacy of Clonidine can be decreased when used in combination with Piroxicam.]
[J01MA11, grepafloxacin, The metabolism of Clonidine can be decreased when combined with Grepafloxacin.]
[N02CX01, pizotyline, The risk or severity of sedation can be increased when Clonidine is combined with Pizotifen.]
[J05AG02, delavirdine, The metabolism of Clonidine can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The risk or severity of hypotension can be increased when Clonidine is combined with Irbesartan.]
[N05CA22, proxibarbal, The risk or severity of sedation can be increased when Clonidine is combined with Proxibarbal.]
[A03AE01, alosetron, The risk or severity of sedation can be increased when Clonidine is combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Clonidine can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The risk or severity of hypotension can be increased when Clonidine is combined with Polythiazide.]
[J05AE03, ritonavir, The serum concentration of Clonidine can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The metabolism of Clonidine can be decreased when combined with Saxagliptin.]
[A10AD04, insulin lispro, The therapeutic efficacy of Insulin lispro can be increased when used in combination with Clonidine.]
[C07AB01, practolol, The risk or severity of hypotension can be increased when Clonidine is combined with Practolol.]
[N05BA11, prazepam, The risk or severity of sedation can be increased when Clonidine is combined with Prazepam.]
[P02BA01, praziquantel, The metabolism of Clonidine can be decreased when combined with Praziquantel.]
[C02CA01, prazosin, The risk or severity of hypotension can be increased when Prazosin is combined with Clonidine.]
[S03BA02, prednisolone, The metabolism of Clonidine can be increased when combined with Prednisolone.]
[C01DX02, prenylamine, Clonidine may increase the atrioventricular blocking (AV block) activities of Prenylamine.]
[N01BB04, prilocaine, The risk or severity of sedation can be increased when Clonidine is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Clonidine can be decreased when combined with Primaquine.]
[N03AA03, primidone, The risk or severity of sedation can be increased when Clonidine is combined with Primidone.]
[M04AB01, probenecid, The metabolism of Clonidine can be increased when combined with Probenecid.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Clonidine.]
[S01HA05, procaine, The risk or severity of sedation can be increased when Clonidine is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of sedation can be increased when Clonidine is combined with Procarbazine.]
[C10AB05, fenofibrate, The metabolism of Clonidine can be decreased when combined with Fenofibrate.]
[N05AB04, prochlorperazine, The risk or severity of sedation can be increased when Clonidine is combined with Prochlorperazine.]
[N04AA04, procyclidine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[G03DA04, progesterone, The metabolism of Clonidine can be decreased when combined with Progesterone.]
[N05AA03, promazine, The risk or severity of sedation can be increased when Clonidine is combined with Promazine.]
[R06AD02, promethazine, The risk or severity of sedation can be increased when Clonidine is combined with Promethazine.]
[C01BC03, propafenone, The metabolism of Clonidine can be decreased when combined with Propafenone.]
[N01AX04, propanidid, The risk or severity of sedation can be increased when Clonidine is combined with Propanidid.]
[A03AB05, propantheline, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[N05AC01, periciazine, The risk or severity of sedation can be increased when Clonidine is combined with Periciazine.]
[N05CM06, propiomazine, The risk or severity of sedation can be increased when Clonidine is combined with Propiomazine.]
[L01XH02, romidepsin, The metabolism of Clonidine can be decreased when combined with Romidepsin.]
[N01AX10, propofol, The risk or severity of sedation can be increased when Clonidine is combined with Propofol.]
[N02AC04, propoxyphene, The risk or severity of sedation can be increased when Clonidine is combined with Dextropropoxyphene.]
[C07AA05, propranolol, The risk or severity of hypotension can be increased when Clonidine is combined with Propranolol.]
[C01AB01, proscillaridin, Clonidine may increase the atrioventricular blocking (AV block) activities of Proscillaridin.]
[N02CC04, rizatriptan, The risk or severity of sedation can be increased when Clonidine is combined with Rizatriptan.]
[B01AC09, epoprostenol, The risk or severity of hypotension can be increased when Clonidine is combined with Epoprostenol.]
[N06AA11, protriptyline, The risk or severity of sedation can be increased when Clonidine is combined with Protriptyline.]
[R01BA02, pseudoephedrine, Pseudoephedrine may decrease the antihypertensive activities of Clonidine.]
[N05AX12, aripiprazole, The risk or severity of sedation can be increased when Clonidine is combined with Aripiprazole.]
[A03AB15, diphemanil, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, The risk or severity of sedation can be increased when Clonidine is combined with Talbutal.]
[N05CA09, vinbarbital, The risk or severity of sedation can be increased when Clonidine is combined with Vinbarbital.]
[N05BB02, captodiamine, The risk or severity of sedation can be increased when Clonidine is combined with Captodiame.]
[M03BA04, styramate, The risk or severity of sedation can be increased when Clonidine is combined with Styramate.]
[P02CC01, pyrantel, The risk or severity of sedation can be increased when Clonidine is combined with Pyrantel.]
[R06AC01, pyrilamine, The risk or severity of sedation can be increased when Clonidine is combined with Mepyramine.]
[P01AX05, quinacrine, The metabolism of Clonidine can be decreased when combined with Quinacrine.]
[C01BA01, quinidine, The metabolism of Clonidine can be decreased when combined with Quinidine.]
[P01BC01, quinine, The risk or severity of sedation can be increased when Clonidine is combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Clonidine can be decreased when combined with Ranitidine.]
[C02AA01, rescinnamine, The risk or severity of hypotension can be increased when Clonidine is combined with Rescinnamine.]
[C02AA02, reserpine, The risk or severity of sedation can be increased when Clonidine is combined with Reserpine.]
[J04AB02, rifampin, The metabolism of Clonidine can be increased when combined with Rifampicin.]
[R03AC05, rimiterol, Rimiterol may decrease the antihypertensive activities of Clonidine.]
[G02CA01, ritodrine, Ritodrine may decrease the antihypertensive activities of Clonidine.]
[N06AX01, 5-hydroxytryptophan, The risk or severity of sedation can be increased when Clonidine is combined with Oxitriptan.]
[J01FA06, roxithromycin, The metabolism of Clonidine can be decreased when combined with Roxithromycin.]
[N02BA05, salicylamide, The therapeutic efficacy of Clonidine can be decreased when used in combination with Salicylamide.]
[A07EC01, sulfasalazine, The therapeutic efficacy of Clonidine can be decreased when used in combination with Sulfasalazine.]
[S01BC08, salicylic acid, The therapeutic efficacy of Clonidine can be decreased when used in combination with Salicylic acid.]
[S01FA02, scopolamine, The risk or severity of sedation can be increased when Clonidine is combined with Scopolamine.]
[N05CA06, secobarbital, The risk or severity of sedation can be increased when Clonidine is combined with Secobarbital.]
[N04BD01, selegiline, The risk or severity of sedation can be increased when Clonidine is combined with Selegiline.]
[L01FA03, obinutuzumab, Clonidine may increase the hypotensive activities of Obinutuzumab.]
[H01CB01, somatostatin, The metabolism of Clonidine can be decreased when combined with Somatostatin.]
[C07AA07, sotalol, The risk or severity of bradycardia can be increased when Clonidine is combined with Sotalol.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Clonidine.]
[C03DA01, spironolactone, The therapeutic efficacy of Clonidine can be decreased when used in combination with Spironolactone.]
[N05CC01, chloral hydrate, The risk or severity of sedation can be increased when Clonidine is combined with Chloral hydrate.]
[N03AG01, valproic acid, The risk or severity of sedation can be increased when Clonidine is combined with Valproic acid.]
[D07AB02, hydrocortisone butyrate, The metabolism of Clonidine can be increased when combined with Hydrocortisone butyrate.]
[H02CA04, levoketoconazole, The metabolism of Clonidine can be decreased when combined with Levoketoconazole.]
[R03BB01, ipratropium bromide, Clonidine may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
